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1.0  Abstract 
Ire1 is a protein kinase endoribonuclease (RNase) and a resident protein of the 
endoplasmic reticulum (ER) of Saccharomyces cerevisiae and a homologue to the Ire1a 
ER protein found in humans. Ire1 activates splicing of the mRNA of the unfolded protein 
response (UPR) gene HAC1. This splicing is a response to the accumulation of unfolded or 
misfolded proteins in the ER lumen. Splicing of HAC1 mRNA results in the translation of 
the Hac1 protein Hac1i which contains a bZIP transcription factor which promotes the 
expression of UPR-associated genes which ultimately leads to the alleviation of ER stress. 
The activation of Ire1 was previously thought to be dependent on phosphorylation within 
the Ire1 activation loop (a-loop). Here it is shown that in “phospho-dead” mutants, some 
level of splicing and UPR-activity is retained and that the aspartic acid residue (D836) 
within the a-loop allows for this retention. Furthermore, it was confirmed that mutation of 
D836 to alanine completely eliminates HAC1 mRNA splicing. This work suggests that 
phosphorylation of the a-loop is critical but not essential to RNase activation and the UPR. 
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6.0  Introduction 
6.1 The unfolded protein response 
Resident molecular chaperones and protein foldases in the endoplasmic reticulum (ER) 
prevent the aggregation and accumulation of unfolded and misfolded proteins (Gething and 
Sambrook, 1992; Stevens and Argon, 1999; Credle et al., 2005). Under normal cellular 
conditions the rate of protein folding and the levels of secretory protein synthesis is 
balanced (Joshi et al., 2015). When ER stress is induced by the accumulation of unfolded 
or misfolded proteins there must be a response from the cell allowing for tolerance of this 
stress (Walter and Ron, 2011). This response must facilitate the appropriate processing of 
unfolded proteins to maintain cell survival (Cox et al., 1993). Accumulation of proteins 
can occur as a result of the inefficient or slow protein folding capacity of the ER (Smith et 
al., 2011) and the resulting ER stress is a critical aspect in a number of diseases including 
type II diabetes (Özcan et al., 2004) and neurodegenerative diseases (Nishitoh et al., 2002). 
The unfolded protein response (UPR) is an intracellular signalling pathway which allows 
tolerance and adaptation to the ER stress caused by unfolded protein accumulation in the 
ER (Tanaka et al., 2015). Any proteins that fail to fold, or are incorrectly folded and 
accumulate in the ER are targeted for degradation by endoplasmic reticulum associated 
degradation (ERAD) (Gardner et al., 2013). This degradation is facilitated by poly-
ubiquitylation of the protein in the cytosol, following the removal of the protein from the 
ER lumen by molecular chaperones (Smith et al., 2011). In the event of ER stress, the UPR 
allows the cell to respond by inducing the expression of genes involved in transport of 
accumulated unfolded or misfolded proteins out of the ER for degradation permitting ER 
stress tolerance (Snapp, 2012). Specific gene expression is facilitated by the splicing of 
HAC1 mRNA. The mature (spliced) mRNA is translated to produce the Hac1 protein 
(Hac1i) which acts a transcription factor (Travers et al., 2000) by binding to the unfolded 
protein response element (UPRE) within the promoter of UPR-associated genes allowing 
for specific induction of UPR genes (Mori et al., 1992).  
The UPR in S. cerevisiae is initiated by Ire1 (Wiseman et al., 2010). Ire1 is a type I 
transmembrane protein, possessing ER lumenal and cytosolic domains. Within the 
cytosolic domain there is a serine/threonine-specific protein kinase element (Shamu and 
Walter, 1996) and an endoribonuclease (RNase) element (Mori, 2000). These elements are 
critical in the activation of the UPR. Fig. 1 below shows the structure of Ire1 across the ER 
membrane and the elements of both the lumenal and the cytosolic domains. 
	 10	
 
Fig 1. Schematic of Ire1 protein showing its lumenal and cytosolic domains. (A) 
shows the arrangement of Ire1 when under no ER stress and the inactive RNase 
domain. (B) Unfolded proteins initiate dimerisation or possibly oligomerisation of 
the Ire1 lumenal domain element. Following this, the kinase domain is activated by 
either phosphorylation of the a-loop (Lee et al., 2008; Nolen et al., 2004) or by 
oligomerisation which is stabilised by phosphorylation of the a-loop (Korennykh et 
al., 2009). Binding of ATP results in trans-autophosphorylation of the activation 
loop (a-loop) of neighboring Ire1 molecules (Gardner et al., 2013). The hydrolysis 
of the ATP by the kinase domain promotes the RNase active conformation (Lee et 
al., 2008). Once activated, the RNase element is involved in the splicing of HAC1 
mRNA to produce the induced protein Hac1i resulting in expression of UPR-
associated genes including genes encoding for molecular chaperones or ERAD-
associated protein machinery (Snapp, 2012). 
It is the cytosolic elements that are of interest in the role of phosphorylation in activation 
and regulation of the UPR as they contain the protein kinase and RNase domains. 
Responsibility of nucleotide binding and phosphorylation falls to the kinase domain and 
the cleavage of HAC1 mRNA is facilitated by the RNase domain when in its active 
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conformation. However, in the first instance it is the lumenal domain that detects unfolded 
protein accumulation. 
6.2 Activation of the lumenal domain 
In yeast, Ire1 is the only known sensor to respond to unfolded protein accumulation in the 
ER and transduces this information across the ER membrane (Anken et al., 2014). There 
are two theories regarding how the lumenal domain of Ire1 detects the accumulation of 
unfolded proteins within the ER. One theory is that the Ire1 lumenal domain senses 
unfolded proteins in the ER lumen and directly binds these proteins, allowing for the 
formation of higher order oligomers (Credle et al., 2005; Mathuranyanon et al., 2015; 
Pincus et al., 2010). Alternatively, it is proposed that proteins such as Kar2 (BiP) act as 
regulators by binding to the Ire1 lumenal domain receptor and do so in competition with 
unfolded proteins (Kimata et al., 2007; Shamu and Walter, 1996; Zhou et al., 2006); (Fig. 
1). To take the example of molecular regulators, under ER stress conditions unfolded 
proteins are more numerous and compete for binding to Ire1 with molecular regulators. 
This reduces the occurrence of regulator binding to the Ire1 lumenal domain and increases 
the occurrence of the binding of unfolded proteins, allowing for dimerisation of the Ire1 
lumenal domain and autophosphorylation of its neighbours (Liu, Schröder and Kaufman, 
2000), which ultimately activates the UPR. Both theories agree that the dimerisation or 
oligomerisation of the lumenal domain of Ire1 is essential for signal propagation across the 
membrane. It may indeed be the case that both theories are correct and the lumenal domain 
of Ire1 can be activated by multiple methods (Snapp, 2012). The lumenal domain is not 
simply a detection domain for ER stress, it is a precursor for downstream signalling (Liu et 
al., 2000). Ire1 has been show to produce foci sites in vivo when ER stress is induced. 
Furthermore, these clusters of Ire1 were no longer visible when cells were washed and 
incubated in conditions that did not induce ER stress, suggesting that these clusters are not 
simply aggregates of Ire1 (Kimata et al., 2007) but directly linked to the UPR. 
Additionally, clustering was observed in a kinase inactive mutant as well as a HAC1 
knockout mutant (Kimata et al., 2007). This suggests that kinase activity and UPR-
associated gene expression are not prerequisites for the formation of clusters of Ire1, but 
that the clustering of Ire1 is required for UPR activation. Should Ire1 not cluster upon the 
induction of ER stress then it is suggested that the UPR would not be induced, or induced 
at a reduced capacity due to the lack of Ire1 activation (Credle et al., 2005). This is 
supported by evidence that point mutations that prevent or deform interfaces between Ire1 
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molecules in the lumenal domain, involved in dimerisation or oligomerisation, reduce Ire1 
activity suggesting that the formation of interfaces is critical both in the lumenal and 
cytosolic domains of Ire1 (Credle et al., 2005). 
6.3 The Kinase domain of Ire1 and its role in RNase domain activation 
Specific elements of the role of the kinase domain of Ire1 are still unknown, such as the 
specific role phosphorylation of the a-loop plays in how Ire1 regulates RNase activity. 
Regions, within the kinase domain such as the activation loop (a-loop), the magnesium 
binding loop, the b10 domain, and the P+1 region (collectively known as the activation 
segment, Fig. 2) are critical to the regulation of RNase activity of Ire1. This is because 
these conserved regions contain residues thought to be involved in phosphorylation 
(serines 837, 840, 841, and 850 and threonine 844 (Lee et al., 2008; Shamu and Walter, 
1996)), and interactions involved in kinase activity (aspartic acid 828 (D828) (Papa et al., 
2003)). The a-loop is thought to promote trans-autophosphorylation of positive regulatory 
sites within the protein kinase domain, namely serine 840 and 841 (S840 and S841) as a 
minimum (Shamu and Walter, 1996). Trans-autophosphorylation of Ire1 by neighbouring 
Ire1 molecules is thought to result in an active conformation of the cytosolic domain and 
subsequent activation of the RNase domain of Ire1 (Sidrauski and Walter, 1997; Welihinda 
and Kaufman, 1996). Autophosphorylation of S841 and threonine 844 (T844) was found to 
be a requirement of Ire1 kinase domain activation (Korennykh et al., 2009; Lee et al., 
2008; Mannan et al., 2013). Furthermore, mass spectroscopy revealed phosphorylation on 
the previously reported serine residues (S840 and S841) (Shamu and Walter, 1996) as well 
as at T844 and serine 850 (S850) (Lee et al., 2008). However, subsequent investigation of 
S850 found that mutation at this residue did not result in impairment of Ire1. S837 was first 
suggested as possible phosphorylation sites in the 1990’s (Shamu and Walter, 1996) 
however there is no primary data thus far to support this.  
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Fig. 2 The conservation of phosphorylation sites within the activation loop of S. 
cerevisiae. The S840 and S841 residues show a high level of conservation, within 
the a-loop, this is also true for T844. S837 and S850 however show lower levels of 
conservation. This inclusion of the S837A residue to the P-A mutant (S837A-
S840A-S841A-T844A-S850A) and its exclusion from the Q-A mutant (S840A-
S841A-T844A-S850A) allows its role in Ire1 activation to be characterised, as this 
information is presently not available in the literature. The aspartic acid at position 
836 (D836) can also be studied by this design. With the inclusion and exclusion of 
an alanine mutation at D836 (D836A) the effect of the combination of D836A with 
phospho-mutants on UPR activation can be investigated. Through the construction 
of mutants containing different combinations of different mutation sites within the 
activation segment (Mg2+, b10, the activation loop and P+1 domains) it is possible 
to investigate the possible role the mutated residues may have on Ire1 activation.   
D828 is a critical residue in the catalytic loop of the kinase domain of Ire1 as it coordinates 
the b and g phosphates of ATP with Mg2+ in the kinase pocket (Chawla et al., 2011; 
Korennykh et al., 2011). This residue is found in the region of the activation segment 
known as the magnesium binding loop (Fig. 2). Mutants possessing the D828A mutation 
have been described as “kinase dead” due to the lack of a protein kinase active site (Papa et 
al., 2003), although the concentration of the kinase inhibitor used (20 µM) should be taken 
	 14	
into consideration regarding disassociation rates whereby this may be insufficient to 
represent Ire1 function when binding nucleotide. Furthermore, D797 and K799 residues 
have been identified as catalytic sites with a predicted function of coordination of the g 
phosphate of ATP bound to the kinase domain (Rubio et al., 2011). It has been shown that 
the binding of a kinase inhibitor can still result in RNase activity (Papa et al., 2003) 
suggesting the importance of nucleotide binding induced conformation changes in the 
kinase domain. Also, previous unpublished work in the Schröder Laboratory at Durham 
University found that with mutants lacking kinase activity (K799A, N802A, and D828A) 
show a retention of levels of RNase activity close to that found in the wild type (WT) 
(Chawla et al., 2011; Rubio et al., 2011). This suggests that kinase activity may be 
dispensable in terms of RNase activation. 
In the examples above the RNase domain was still activated, suggesting that RNase 
activation could still be occurring due to the occupation of adenine and ribose subsites, 
thought to stablise the kinase active sites in the open conformation favouring Ire1 self-
association (Korennykh et al., 2009). An example of Ire1 self-association with the binding 
of ADP to the nucleotide binding pocket (NBP) can be seen in Fig. 3.  
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Fig. 3 The crystal structure of the cytosolic domain of a pair of Ire1 proteins (Lee 
et al., 2008). The figure highlights the binding of ADP to the NBP. The RNase 
domain, located within the kinase-extension nuclease (KEN) region on this figure 
(blue) facilitates HAC1 mRNA splicing. The a-loop is indicated in the kinase 
domain. Dashed lines within this figure indicate these regions failed to be fully 
modeled due to disorder. 
Despite numerous factors in kinase domain activation, the key to RNase activation seems 
to be the conformational change of the kinase domain resulting from kinase activation, 
either from a-loop interactions (Lee et al., 2008; Nolen et al., 2004) or oligomerisation 
(Korennykh et al., 2009). This is important as it is the RNase activation which facilitates 
HAC1 mRNA splicing allowing for induction of UPR-associated genes. 
6.4 HAC1 mRNA splicing by the Ire1 RNase domain 
The Ire1 signaling cascade ultimately causes activation of the cytosolic RNase domain of 
Ire1 (Tanaka et al., 2015). In order to produce functioning protein (Hac1i), HAC1 mRNA 
must be spliced, removing a 252-nucleotide sequence, (Mori, 2000) (Fig. 4), removing the 
intron which contains a transcriptional attenuator (Rüegsegger et al., 2001). The remaining 
a-loop	
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two exons are ligated by tRNA ligase (Gardner et al., 2013) and translated. Without the 
removal of the intron HAC1 mRNA remains untranslated due to an interaction between the 
intron (still in the sequence) and the 5’-untranslated region (5’ UTR) of HAC1 
(Rüegsegger et al., 2001; Sathe et al., 2015). The translated Hac1i contains a potent bZIP 
transcription factor (Gardner et al., 2013). It is this transcription factor that is required for 
the expression of UPR genes including KAR2, PDI1 and LHS1, which code for molecular 
chaperones (Schröder, Chang and Kaufman, 2000) and aid in the tolerance and recovery 
from ER stress.  
 
Fig. 4 The intron of HAC1 mRNA to be spliced; U indicating unspliced mRNA and 
S indicating spliced mRNA. HAC1 being the yeast mRNA, bZIP60 the mRNA of 
plants and XBP1 the mRNA of metazoans (Zhang et al., 2016). The red aligned 
bases indicate conservation of the mRNA sequence. 
In order to express UPR-associated genes, the bZIP transcription factor of Hac1i associates 
with a conserved promoter sequence known as the unfolded proteins response element 
(UPRE) (Mori et al., 1992; Kohno et al., 1993; Kimata et al., 2003; Montenegro-Montero 
et al., 2015). This UPRE is what gives the UPR it’s specificity in gene expression 
response.  
6.5 Activation loop phosphorylation and its role in RNase activation 
There are currently two models that differ slightly in their thoughts regarding 
phosphorylation of the a-loop and RNase activation. The first model is based on 
phosphorylation of the a-loop resulting in conformational changes in the a-loop and kinase 
domain which facilitates nucleotide binding. These conformational changes promote 
kinase activity resulting in the hydrolysis of ATP to ADP. The resulting ADP bound state 
positions the Ire1 in a dimer and the RNase domain is activated, potentiated by ADP in the 
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NBP (Lee et al., 2008; Shamu and Walter, 1996). It has been suggested that the 
phosphorylated a-loop interacts with specific residues of the kinase domain to promote the 
conformational changes mentioned. When the active state of a cyclic adenosine 
monophosphate- (cAMP) dependent kinase structure was solved it showed the interaction 
between a phospho-residue within the a-loop and residues on the surface of the kinase 
domain due to their positive charge (Knighton et al., 1991). This interaction takes place at 
a conserved arginine preceding a conserved aspartic acid within the catalytic loop of the 
kinase, which allows for regulation of kinase activity (Johnson et al., 1996). The arginine 
and aspartic acid residues were named the “RD pocket” and kinases that possessed this 
pocket were termed RD kinases. In RD kinases, the electrostatic interaction between 
phospho-residues within the a-loop and the RD pocket is critical for driving the 
conformational change required for kinase activity (Nolen et al., 2004). Nolen et al., 
(2004) suggest that the arginine does not directly relay a signal of activation to the kinase 
catalytic loop, but that the change in the a-loop structure mediated by the RD pocket, 
facilitates the conformational change to the N and C-terminal anchors of the a-loop 
allowing for nucleotide binding, a step thought to be essential in Ire1 activation (Papa et 
al., 2003). Additionally, this model also supports the idea that phosphorylation can be 
bypassed in phosphorylation-independent protein kinases.  In the case of phosphorylation-
independent RD kinases, stabilising the active conformation of the a-loop can be achieved 
with the use of separate regulatory domains or changes within the amino acid sequence 
within the kinase domain (Nolen et al., 2004). The negative charge of a glutamate residue 
within the a-loop allows for pocket stabilisation in phosphorylase kinase (PhK) (Johnson et 
al., 1996) and the use of glutamates in the a-loop Ire1 also suggested this (Mannan et al., 
2013). The stabilisation of the RD pocket by these methods may further promote 
nucleotide binding. This illustrates a possible mechanism of kinase activation independent 
of phosphorylation within the a-loop.  
A variation on this model, presented by Korennykh et al., (2009), is that the cytosolic 
domain forms an oligomer via a two step process. Initially the cytosolic domain forms 
back-to-back dimers. To promote the self-association required for the initial dimer and 
subsequent oligomer formation, the adenosine and ribose subsites of Ire1 should be 
occupied (Korennykh et al., 2009), which is suggested to be completed by ADP binding to 
the unphosphorylated Ire1. This self-association is thought to promote a conformational 
change within Ire1 permitting kinase activity, trans-autophosphorylation and subsequent 
ATP binding. The binding of ATP to the now active kinase domain results in 
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phosphorylation of the a-loop and the locking of Ire1 into an oligomerisation compatible 
state. This oligomerisation-compatible state is facilitated by a phosphate-mediated salt 
bridge at IF3c resulting from ATP binding. The IF3c interface is believed to be essential for 
the formation of higher order oligomers (Korennykh et al., 2009). The growth of the 
oligomer relies on the formation and cooperation of three interfaces, (IF1c, IF2c and IF3c). 
Interface 3 (IF3c) links the cytosolic domain monomers. Interfaces 1 (IF1c) and 2 (IF2c) 
link the kinase domains (Lee et al., 2008) and the RNase domains of the associated 
monomers respectively. This sequence of events results in a form of positive feedback, as 
the creation of salt bridges at IF3c facilitates the addition of more Ire1 molecules forming a 
higher-order oligomer. The dimers are added to the growing oligomer at a rate of one for 
every 51.4º of clockwise turn. This Ire1 oligomer and its associated interfaces are believed 
to control the RNase activity of Ire1 (Korennykh et al., 2009). It is suggested that IF1c and 
IF2c form a continuous linkage of the RNase domains within the oligomer and that IF2c 
stabilises the helix-loop element (HLE) of the RNase domain which is believed to control 
RNase activity (Korennykh et al., 2009). This model considers oligomerisation as the 
critical step in RNase activation, with a-loop phosphorylation playing more of a supportive 
role by stabilising oligomer-associated interface formation. Trans-autophosphorylation in 
the oligomer model could be the solution to the issue of how Ire1in a dimer would trans-
autophosphorylate when the a-loops are positioned more than 40 Ångströms (Å) away 
from one another, an arrangement which would seem unproductive in terms of the trans-
autophosphorylation observed in vivo (Shamu and Walter, 1996) (A-loop position in Fig. 
3).  
Although these two theories share some themes, they differ in that the first model is based 
on phosphorylation being the driving force in kinase activation and the resulting RNase 
activity whereas oligomerisation is the critical step in kinase activation and RNase activity 
in the alternative model. The models also share some flaws. In the first model, the 
interaction between the phosphorylated a-loop and the RD pocket is thought to facilitate a 
conformational change to facilitate nucleotide binding. As Ire1’s phosphorylation is based 
on autophosphorylation this would suggest that there must already be kinase activity to 
phosphorylate the a-loop. This could be explained by two theories. The first is that the 
kinase domain always has levels of ATP binding due to the high concentration of ATP in 
the cell but that its kinase function is very low. When the a-loop becomes phosphorylated 
the conformation change in the kinase domain permits more efficient kinase function, 
dramatically increasing the rate of a-loop phosphorylation. As the Ire1 molecules are 
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brought together under ER stress this increases a-loop phosphorylation results in the 
increase of trans-autophosphorylation outlined in the model. Alternatively, the active and 
inactive status of the kinase domain may be in equilibrium. The activation and clustering 
of Ire1 through ER stress brings the Ire1 molecules together which tips this equilibrium to 
favour the active ATP-binding state. This balance tilt is because, as the trans-
autophosphorylation between the ATP bound Ire1 occurs, this will promote conformational 
changes to the inactive Ire1 which in turn activates other inactive Ire1 kinase domains 
through trans-autophosphorylation.  
With the RNase activation model based on oligomerisation, ADP binds to initiate the 
oligomer, which promotes the conformational change in the kinase domain. So how does 
nucleotide bind to inactive kinase? The answer to this may be that the kinase domain can 
bind nucleotides but has no kinase activity in this non-oligomer conformer. ADP simply 
allows for the formation of the initial dimer/oligomer, which results in a conformational 
change within the kinase domain. Under no ER stress this would not result in dimerisation 
as Ire1 would not be brought together by the lumenal domain. This puts the kinase domain 
in its active state allowing ATP binding and trans-autophosphorylation permitting the 
formation of oligomers. 
In the models described above, phosphorylation is involved in either the activation of the 
kinase domain or formation of oligomers, both of which are claimed to result in the 
activation of the RNase domain. The activation of the RNase domain of Ire1 results in 
HAC1 mRNA splicing which, when translated produce the Hac1i protein, acts a 
transcription factor for UPR-associated genes by interacting with the UPRE within the 
promoter of UPR-associated genes (Mori et al., 1992; Kohno et al., 1993; Kimata et al., 
2003; Montenegro-Montero et al., 2015).  From this, a complete loss of HAC1 mRNA 
splicing in vivo would be expected in mutants possessing mutations in all of the a-loop 
phosphorylation sites of Ire1, as in the absence of phosphorylation it is expected that 
RNase activation would not occur (if indeed Ire1 is phosphorylation-dependent) (Shamu 
and Walter, 1996). In the case of S840A-S841A, Q-A and P-A mutants (Fig. 2) it has been 
found that this is not the case (unpublished work from the Schröder Laboratory, Durham 
University). Data showed that a reduced level of RNase activity was being retained, 
indicated by the presence of spliced HAC1 mRNA on a northern blot (Fig.5).  
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Fig 5. Northern blot data of a-loop phospho-mutants and D836A mutants, data 
gathered by Dr. Martin Schröder. The presence of the top row of bands of the 
HAC1 section indicates the levels of unspliced HAC1 mRNA, the second row of 
bands is the spliced HAC1 mRNA coding for the active Hac1i protein. KAR2 and 
PDI1 are UPR-associated genes and the increasing intensity of bands over time is 
indicative of UPR gene activation, this is complemented by increasing intensity of 
spliced HAC1 bands. pC4/2 is a loading control. The D836A mutant behaves 
much the same as seen in the WT, however, when combined with phospho-
acceptor mutants P-A, Q-A and S840A-S841A the residual HAC1 mRNA detection 
is further attenuated to almost undetectable levels. 
The Schröder Laboratory at Durham University also found that with mutations of specific 
residues, K799A, N802A, and D828A no protein kinase activity was recorded but levels of 
RNase activity close to that found in the wild type (WT) were observed (Rubio et al., 
2011). These mutants were found to suffer no loss in ATP or ADP binding efficiency in 
vitro, and furthermore rescued the RNase activity of a kinase defective mutant, D797A. 
This lead to the proposition that the phosphorylation of the a-loop by the kinase activity of 
A 
B 
Unspliced	
Spliced		
Unspliced	
Spliced		
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Ire1 does not play an indispensable role in the binding of nucleotides, oligomerisation or 
RNase activity. This lead to the question, if there were small levels of RNase activity 
detected by the presence of spliced HAC1 mRNA, by what mechanism was Ire1 being 
activated the was independent of phosphorylation? The addition of a mutation of the 
aspartic acid 836 (D836) to an alanine (D836A) to the same phospho-residue mutants 
(S840A-S841A, Q-A and P-A), resulted in spliced HAC1 mRNA levels which appeared to 
be the same as those found in the negative control suggesting that D836 plays a role in 
RNase activation (Fig. 5). The conclusions were that the D836 residue may act as a 
substitute for phosphorylation within the a-loop and that the kinase domain is involved in 
control of the RNase activity only after nucleotide(s) binding to the NBP.  
If the D836 residue facilitates the retention of attenuated levels of RNase activity, then this 
may allow for RNase domain activation (at a reduced level) and induction of the UPR 
without the requirement for phosphorylation within the a-loop. As mentioned earlier, the 
positive charges within the kinase domain catalytic site interact with the negative charges 
of the a-loop (in the RD model) are thought to interact, allowing for nucleotide binding. 
Aspartic acid is negatively charged hence the D836 residue may mimic this interaction and 
the substitution of aspartic acid for alanine prevents this imitation of phosphorylation 
interaction. The reasoning behind only a partial retention of RNase activity may be 
because of the theory that there is a preferential order to phosphorylation sites within the a-
loop of protein kinases, with one site being known as the primary site (Nolen et al., 2004; 
Shamu and Walter, 1996). This would suggest that this primary site would have the largest 
impact on kinase activation, therefore a secondary site less so, and a compensatory system, 
such as proposed here with D836 may have even more limited kinase activation ability. 
6.6 Aims and objectives 
A hypothesis investigating if D836 can substitute for phosphorylation of phospho-acceptor 
sites in the a-loop of Ire1 in the event of loss of phospho-activity was tested. The goal of 
the hypothesis being to further characterise the role of phosphorylation in the a-loop of 
Ire1 and the role this plays on RNase activity. The aims were to; 1. Characterise the levels 
of Ire1 expression in the mutants used. 2. To investigate how phosphorylation mutations 
within the a-loop effect ER stress signal transduction by Ire1 and to what extent D836 
played a role in retention of signal transduction if phospho-mutants. 3. The further review 
of the ER stress tolerance in phospho-acceptor mutants and if D836A-inclusive phospho-
mutants were further affected by ER stress in vivo. 4. To review the clustering of Ire1 in 
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mutants in response to ER stress. These four goals were achieved using a range of mutants 
of Saccharomyces cerevisiae to monitor the unfolded protein response to ER stress, 
S840A-S841A, D836A-S840A-S841A, Q-A (S840A-S841A-T844A-S850A) and D836A-
Q-A and P-A (S837A-S840A-S841A-T844A-S850A), D836A-P-A (Details in Fig. 2). By 
comparing the D836A-inclusive mutants to the non-D836A mutants, and any change in the 
unfolded protein response, the role D836 plays in the activation of the RNase activity in 
Ire1 could be further characterised. If the hypothesis regarding the ability of D836 to 
bypass phosphorylation is correct, a complete loss of UPR activation should occur with the 
inclusion of D836A to phospho-acceptor mutants.  To test the UPR, the ER of cells will be 
stressed with 2 mM dithiothreitol (DTT) (or increasing concentrations of DTT and 
tunicamycin (Tn) in spotting assays) to induce ER stress by preventing di-sulphide bond 
formation and prevent glycosylation respectively. This should result in the introduction of 
ER stress. Sections 6.6.1 – 6.6.4 briefly explain these approaches. 
6.6.1 Ire1 protein expression in mutants 
Western blot analysis utilising the HA-tagged Ire1 allows for evaluation of the steady-state 
expression levels of Ire1 of the mutants. Should the mutants be lacking in Ire1 or show the 
phenotype of a dramatic reduction or induction of Ire1 then this would serve as an 
explanation as to any differences in ER stress response. The standardisation of Ire1 protein 
against an abundant non-UPR-associated protein (in this case b-actin) allows for 
comparison between mutants. 
6.6.2 b-galactosidase-reporter assay to determine activation of the UPR  
In unstressed cells, HAC1 mRNA is not readily translated, however, when ER stress is 
introduced the resulting splicing and ligation of HAC1 mRNA produces a translatable 
mRNA coding for Hac1i (Bertolotti and Ron, 2001). Translation of Hac1i will result in 
expression of UPR-associated genes through UPRE interaction (Mori et al., 1996), 
detectable with the reporter assay. The northern blot data gathered (Fig. 5) shows levels of 
mRNA (both spliced and unspliced) over the time course of ER stress. Fig. 5 also shows 
mRNA levels of KAR2. However, due to the unstable nature of RNA these data are not 
necessarily indicative of protein levels in vivo under ER stress, only of the splicing 
achieved by the RNase domain quantified by the detected levels or mRNA. Systems such 
as the UPR need to be evaluated not only by mRNA expression profiles but in terms of the 
activity of proteins. The common occurrence of post-transcriptional regulation and 
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modification of mRNA make mRNA expression profiles alone imperfect in understanding 
a process such as ER stress response (Ghaemmaghami et al., 2003). The use of the UPRE-
associated-b-galactosidase-reporter assay will quantify the UPRE-associated reporter 
protein (b-galactosidase) in the lysate extract and this will allow for quantification of any 
subtle differences in the ER stress signal transduced by Ire1 in the mutants. The use of 
mutants constructed in the way used in this work (Fig. 2) will allow for an assessment of 
how much particular phosphorylation sites impact the UPRE-associated reporter activity.  
6.6.3 Effect of ER stress tolerance in vivo 
Spotting assays allow for the effect of a reduction in ER stress tolerance to be reviewed in 
vivo. Any deficiencies in ER stress tolerance, as a result of the mutations made to Ire1, will 
result in reduced survival of ER stress, indicated by a reduction in growth of colonies. By 
increasing the concentrations of ER stressors (DTT and Tn) over several agar plates the 
capability of the UPR to respond to ER stress can be viewed at different ER stressor 
concentrations. This is critical as the UPRE-associated reporter protein assays are in vitro 
and only show the response from the UPR at the time point at which samples were 
prepared. Spotting assays allow the impact of any mutations to Ire1 to be reviewed in vivo 
allow for study of the effect of the mutations on cell fate. 
6.6.4 Visualisation of the clustering of Ire1 under ER stress 
When the lumenal domain of Ire1 is activated it is known to form clusters in vivo (Aragón 
et al., 2009; Kimata et al., 2007). To view this fluorescence microscopy is to be used. 
Through the labelling of Ire1 using mCherry, clustering of Ire1 can be viewed in real time. 
Additionally, the labelling of the Sec63 protein with GFP allows for localization of the 
Ire1clusters to the ER membrane.  The use of real time in vivo imaging of the clustering of 
Ire1 under ER stress allows for confirmation that the decreased HAC1 mRNA splicing 
observed (Fig. 5) is not a result of a defect in Ire1 clustering.  
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7.0 Materials and Methods 
7.1  Materials 
7.1.1 Buffers and solutions 
Tables 1 and 2 outline the composition of the buffers and solutions used in the work 
presented, where appropriate catalogue numbers and supplier information has been 
provided. 
 
Table 1. Commonly used solutions and buffers and their composition. 
Solution Quantity Recipe 
EDTA, 0.5 M 500 ml 
1. Dissolve 93.1 g Na2EDTA·2H2O in ~350 ml 
H2O. 
2. Adjust pH to 8.0 with 10 M NaOH (~25 ml) 
3. Add H2O to 500 ml. 
4. Autoclave. 
MgCl2, 1 M 100 ml 
1. Dissolve 20.33 g MgCl2·6 H2O in ~ 80 ml H2O. 
2. Add H2O to 100 ml. 
3. Autoclave. 
Na2CO3, 1 M 500 ml 
1. Dissolve 53.0 g Na2CO3 in ~ 400 ml H2O. 
2. Add H2O to 500 ml. 
NaH2PO4, 0.4 M 500 ml 
1. Dissolve 24 g NaH2PO4 in ~400 ml H2O. 
2. Add H2O to 500 ml. 
3. Autoclave. 
Na2HPO4, 0.4 M 500 ml 
1. Dissolve 28.4 g Na2HPO4 in ~400 ml H2O. 
2. Add H2O to 500 ml. 
3. Autoclave. 
10% (w/v) SDS 500 ml 
1. Dissolve 50 g SDS in ~450 ml H2O. 
2. Add H2O to 500 ml. 
3. Do NOT autoclave. 
Tris·HCl (pH 6.8), 1 M 1 l 
1. Dissolve 121.14 g Tris in ~800 ml H2O. 
2. Adjust pH to 6.8 with conc. HCl (~ 42 ml). 
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3. Add H2O to 1 l. 
4. Autoclave. 
Tris·HCl (pH 8.0), 1 M 1 l 
1. Dissolve 121.14 g Tris in ~800 ml H2O. 
2. Adjust pH to 8.0 with conc. HCl (~ 42 ml). 
3. Add H2O to 1 l. 
4. Autoclave. 
10% (v/v) Tween 20 50 ml 
1. Dissolve 5.55 g Tween 20 in ~ 40 ml 
autoclaved H2O. 
2. Add H2O to 50 ml. 
3. Filter sterilise. 
Buffer Composition Quantity Recipe 
50 x TAE 
2 M Tris·HOAc 
0.1 M EDTA 
pH ~ 8.5 
1 l 
242 g Tris 
57.1 ml HOAc 
37.2 g Na2EDTA·2H2O 
Add H2O to 1 l 
1 x TAE 
40 mM 
Tris·HOAc 
2 mM M EDTA 
pH ~ 8.5 
1 l 
20 ml 50 x TAE 
Add H2O to 1 l 
10 x TE (pH 8.0) 
100 mM Tris·HCl 
(pH 8.0) 
10 mM EDTA 
4 l 
400 ml 1 M Tris·HCl (pH 8.0) 
80 ml 0.5 M EDTA 
Add H2O to 4 l 
Autoclave 
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Table 2. Specialist solutions and their composition. 
Solution Composition Quantity Recipe 
30% (w/v) acrylami-
de, 0.8% (w/v) 
methylene bisacryl-
amide 
30% (w/v) acrylamide 
0.8% (w/v) methylene bisac-
rylamide 
100 ml 
30 g acrylamide 
0.8 g methylene 
bisacrylamide 
Dissolve in ~90 ml H2O, add 
H2O to 100 ml. Add 5 g Do-
wex MR-3 mixed bed ion ex-
changer, and stir for 1 h at 
RT. Filter over a 0.22 µm 
filter and store at 4ºC in the 
dark. 
50 mg/ml ampicillin 50 mg/ml ampicillin 50 ml 
2.5 g ampicillin, sodium salt 
Dissolve in ~40 ml H2O, add 
H2O to 50 ml, and filter 
sterilise. Store in 1.0 ml 
aliquots at -20°C. 
2 x assay buffer 
200 mM NaxH3-xPO4 (pH 7.3) 
2 mM MgCl2 
100 mM b-mercaptoethanol 
1.33 mg/ml 2-nitrophenyl-b-
D-galactopyranoside 
 
400 ml 
177 ml 0.4 M Na2HPO4 
 23 ml 0.4 M NaH2PO4 
 0.8 ml 1 M MgCl2 
 2.8 ml b-mercaptoethanol 
   532 mg 2-nitrophenyl-b-D-
galactopyranoside 
Add H2O to 400 ml and mix. 
Store in 50 ml aliquots 
at -20°C. 
1 M dithiothreitol 1 M dithiothreitol (DTT) 10 ml 
1.54 g dithiothreitol 
Dissolve in ~ 9 ml H2O. 
Add H2O to 10 ml. 
Filter sterilise. 
Store at -20°C. 
Use at 2 mM to inhibit 
protein folding in the yeast 
ER. 
10 x DNA gel elec-
trophoresis sample 
loading buffer 
20% (w/v) Ficoll 400 
0.1 M EDTA 
1% (w/v) SDS 
2.5 g/l bromophenol blue 
50 ml 
10 g Ficoll 400 
125 mg bromophenol blue 
10 ml 0.5 M EDTA (pH 8.0) 
Add H2O to ~ 35 ml. 
Dissolve. Add H2O to 45 ml. 
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Autoclave. 
Add 5 ml 10% (w/v) SDS. 
5.0 mg/ml ethidium 
bromide 
5.0 mg/ml ethidium bromide 50 ml 
250 mg ethidium bromide 
Dissolve in ~ 40 ml sterile 
H2O. 
Add sterile H2O to 50 ml. 
Store at 4°C protected from 
light. 
30% (v/v) glycerol 30% (v/v) glycerol 500 ml 
189 g glycerol 
Add H2O to ~400 ml, mix 
well by stirring. Add H2O to 
500 ml and autoclave. 
1 M KH2PO4 1 M KH2PO4 500 ml 
68.05 g KH2PO4 
Add H2O to ~450 ml and 
dissolve. Add H2O to 500 ml 
and filter sterilise. 
1 M K2HPO4 1 M K2HPO4 500 ml 
87.09 g K2HPO4 
Add H2O to ~450 ml and 
dissolve. Add H2O to 500 ml 
and autoclave. 
1 M LiOAc 1 M LiOAc 250 ml 
25.50 g LiOAc·2H2O 
Dissolve in ~200 ml H2O. 
Add H2O to 250 ml. 
Filter sterilise. 
Lysis buffer I 
50 mM NaxH3-xPO4 (pH 7.3) 
150 mM NaCl 
10% (v/v) glycerol 
1 mM EDTA 
500 ml 
14.4 ml 0.4 M NaH2PO4 
48.1 ml 0.4 M Na2HPO4 
4.38 g NaCl 
63 g glycerol 
1 mM 0.5 M EDTA (pH 8.0) 
Add H2O to ~ 400 ml, and 
dissolve. Add H2O to 500 ml. 
Store at 4°C. 
1% (w/v) NaCl 1% (w/v) NaCl 100 ml 
Dissolve 1 g NaCl in ~90 ml 
H2O. Add H2O to 100 ml and 
autoclave. 
50% (w/v) PEG 
4000 
50% (w/v/) PEG 4000 500 ml 
250 g PEG 4000 
Add ~200 ml H2O 
Stir for a few minutes, add 
H2O to ~ 450 ml, stir until 
PEG4000 is nearly 
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completely dissolved, add 
H2O to 500 ml and mix. 
Filter sterilise. 
10 x SDS-PAGE 
buffer 
1.92 M glycine 
0.248 M Tris 
10 g/l SDS 
1 l 
144.13 g glycine 
  30.03 g Tris 
  10.00 g SDS 
Add H2O to ~ 900 ml, stir 
until completely dissolved, 
then add H2O to 1 l. 
6 x SDS-PAGE 
sample buffer 
350 mM Tris·HCl, pH 6.8 
30% (v/v) glycerol 
10% (w/v) SDS 
0.5 g/l bromophenol blue 
2% (v/v) b-mercaptoethanol 
10 ml 
3.50 ml 1 M Tris·HCl, pH 6.8 
3.78 g glycerol 
1.00 g SDS 
1.25 ml 4.0 g/l bromophenol 
blue 
200 µl b-mercaptoethanol 
Add H2O to ~ 9 ml, dissolve 
overnight if necessary. Add 
H2O to 10 ml. 
Semidry transfer 
buffer 
0.1 M Tris 
0.192 M glycine 
5% (v/v) methanol 
1 l 
12.11 g Tris 
14.41 g glycine 
50 ml methanol 
Add H2O to ~900 ml, stir 
until completely dissolved, 
then add H2O to 1 l. 
Stripping solution 
2% (w/v) SDS 
100 mM b-mercaptoethanol 
50 ml 
1 g SDS 
350 µl b-mercaptoethanol 
Dissolve in H2O, then make 
up to 50 ml with H2O. 
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Bicinchoninic acid 
protein assay 
working solution. 
Reagent A: 10 g/l 
bicinchoninic acid disodium 
salt, 20 g/l Na2CO3·H2O, 1.6 
g/l disodium tartrate, 4.0 g/l 
NaOH, 9.5 g/l NaHCO3. 
Adjusted to pH 11.25 with 10 
M NaOH. 
Reagent B: 40 g/l 
CuSO4·5H2O 
15 ml 
Mix 50 parts of reagent A 
with 1 part of reagent B.  
Note: when mixing reagents 
A and B a white precipitate 
may form [Cu(OH)2] this will 
dissolve upon further mixing 
of the reagents. 
10 x TBST 
 
200 mM Tris·HCl, pH 7.6 
1.37 M NaCl 
1% (v/v) Tween 20 
1 l 
Dissolve 24.2 g Tris, 80 g 
NaCl, and 10.6 g Tween 20 in 
~900 ml H2O. Adjust pH 7.6 
to 7.6 with conc. HCl, and 
add H2O to 1 l. 
Note: this was diluted with 
deionised H2O to 1 x for use 
in washing of PVDF 
membranes. 
10 mg/ml 
tunicamycin 
10 mg/ml tunicamycin in 
DMSO 
1 ml 
Add 1 ml DMSO to 10 mg 
tunicamycin (content of one 
bottle). 
Mix to dissolve. 
Store in 50 or 100 µl aliquots 
at -20°C. 
Use at 0.1 – 2.0 µg/ml to 
inhibit protein folding in the 
yeast ER. 
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7.1.2 Media composition for culturing of cells 
Yeast were grown in YPD (2% (w/v) dextrose, 2% (w/v) peptone, 1% (w/v) yeast extract) 
or synthetic medium to maintain plasmids. Synthetic media were prepared using 2% (w/v) 
glucose (Fluka #49138), 0.67% (w/v) yeast nitrogen base without amino acids 
(ForMedium #CYN0405) and 2% agar (ForMedium #AGA03). For plates, agar was added 
to a final concentration of 2% (w/v) before autoclaving the medium. Amino acids were 
added as outlined in Table 3. For b-galactosidase assay experiments an amino acid dropout 
was used to ensure a standard medium throughout the repeats, (complete media 
supplement – uracil dropout, ForMedium #DCS0161), of which 0.77 g were added per litre 
of required broth, total required volume was made up with deionised filtered water. Both 
broth and solid media were autoclaved before use. In microscopy experiments, a medium 
was made using individual amino acids as this protocol requires differing concentrations of 
tryptophan and adenine sulphate (both 100 mg l-1). Amino acid information can be found 
in Table 3.  
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Table 3. The concentrations of components used in the composition of synthetic 
media broths lacking uracil (- U) or lacking Uracil and Leucine (- U - L) for cell 
culture. For solid medium, 2% (w/v) agar was added. L-Asp and L-Thr were added 
after autoclaving. The increased concentrations of tryptophan and adenine in the 
SD-U-L medium are to attempt to reduce or eliminate the auto-fluorescence in 
cells associated with the biosynthetic pathways of these amino acids.  
Component Supplier Cat. No. 
Conc. [mg/l] 
SD-U SD-U-L 
SD-U-L 
(Microscopy) 
L-Tyr 
ForMedium 
Norfolk, UK 
DOC0192 30.00 30.00 30.00 
Uracil ForMedium, UK DOC0213 - - - 
L - Arg·HCl 
Sigma-Aldrich, 
Cramlington, UK 
W38 191 - 8 20.10 20.10 20.10 
L - His·HCl ForMedium, UK DOC0144 20.10 20.10 20.10 
L - Met ForMedium, UK DOC0168 20.10 20.10 20.10 
L - Trp ForMedium, UK DOC0188 20.10 20.10 99.90 
L - Ile ForMedium, UK DOC0152 30.15 30.15 30.15 
L - Lys·HCl ForMedium, UK DOC0161 30.15 30.15 30.15 
L - Val ForMedium, UK DOC0197 150.75 150.75 150.75 
L - Ser ForMedium, UK DOC0181 376.88 376.88 376.88 
Adenine SO4 ForMedium, UK DOC0229 19.95 19.95 99.90 
L - Phe ForMedium, UK DOC0173 49.88 49.88 49.88 
L - Glu 
Calbiochem, 
Watford, UK 
3510 99.75 99.75 99.75 
L - Leu ForMedium, UK DOC0157 100.35 - - 
L - Asp ForMedium, UK DOC0121 100.00 100.00 100.00 
L - Thr ForMedium, UK DOC0185 201.00 201.00 201.00 
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7.1.3 Commercially available kits 
In some cases, commercial kits were used, for example, for plasmid extraction or b - 
galactosidase assays. Such kits are outlines below in Table 4. 
Table 4. The commercial kits used, showing supplier, catalogue number and kit 
used. 
Name of kit Supplier Use Catalogue no. 
E.Z.N.A Plasmid Midi Kit Omega Biotek Plasmid extraction D6904-03 
Perfectprep kit midi Eppendorf Plasmid Extraction Discontinued 
β-Galactosidase Enzyme 
Assay System with 
Reporter Lysis Buffer 
Promega β-Galactosidase assays E2000 
Pierce ™ ECL Western Blot 
Substrate 
Thermofisher 
Scientific 
Chemiluminescent 
detection 
32106 
Pierce ™ ECL Plus Western 
Blot Substrate 
Thermofisher 
Scientific 
Chemiluminescent 
detection 
32132 
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7.1.4 Strain information 
Saccharomyces cerevisiae was used in the work. Specific strains were used with different 
genotypes which are outline in Table 5.   
Table 5. S. cerevisiae strain information. PWY 260 was the strain used for western 
blot and for b-galactosidase experiments, MSY14-02 was used in microscopy work 
due to its more stable expression of the plasmids used in the microscopy work and 
Y01907 was used in spotting assays of the single mutants of the Q-A multipoint 
mutant providing a repeat in another S. cerevisiae strain.  
Strain Genotype Source 
PWY 260 
W303 MATa ire1D::TRP1 ade2-1 can1-100 his3-11,-
15::HIS3+UPRE-lacZ leu2-3,-112::LEU2+UPRE-lacZ trp1-1 
ura3-1 
Papa, 2003 
MSY14-02 CRY1 Dire1::kanMX2 M. Schröder 
Y01907 BY4741 ire1D::kanMX4 
EUROSCARF 
(Winzeler et al., 
1998) 
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7.1.5 Plasmids 
Plasmids were created and transformed into of E. coli (the XL10-GOLD strain) by Dr. 
Sergej Šesták (Slovak Academy of Sciences, Bratislava, Slovakia) and sent to myself to be 
extracted and used in this work. Plasmid maps (Fig. 6) show the use of amino acid 
synthesis markers for the YCplac33 (uracil), pEvA97 (leucine) and pJK59 (uracil) 
plasmids. 
 
 
 
 
C 
B A 
Fig. 6 The plasmids used to 
transform S. cerevisiae cells for 
western blots, b-galactosidase 
assays and microscopy studies. (A) 
YCplac33-IRE1-HA with URA3, 
CEN4-ARS1 and the C-terminal HA-
tag. (B) pJK59 contains URA3 and 
pEvA97 (C) contains LEU2. 
Additionally, pJK59 and pEvA97 
contain the Sec63-GFP and IRE1-
mCherry for microscopy analysis, 
respectively. All plasmids were 
single copy. 
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7.1.6 Antibodies 
The antibodies used to detect the Ire1 tagged with the HA epitope and the actin loading 
control are outlined in Table 6.  
 
Table 6. Antibodies used in the western blot and chemiluminescent detection 
protocol. 
Antibody Species Clonality Supplier Cat. no. Batch/lot no. 
Dilution 
factor 
anti-HA Rabbit Polyclonal 
Sigma-
Aldrich 
H6908 015M4868V 1000 
anti-rabbit IgG 
(H+L)-
peroxidase HRP 
linked 
Goat Polyclonal 
Cell 
Signalling 
7074S 24 2000 
anti-b-actin Mouse 
Monoclonal 
[8F10G10] 
Abcam ab170325 GR184354-8 20,000 
anti-mouse IgG 
(H+L)-
peroxidase 
Goat Polyclonal Pierce 31432 OE17149612 30,000 
 
7.2  Methods 
7.2.1 Plasmid extraction from E. coli 
Plasmid extractions from E. coli were completed using two different commercially 
available kits (Table 4.). Methodologies for each of these kits are outline below. 
7.2.1.1 E.Z.N.A kit 
Following growth of E. coli precultures overnight at 37 ˚C at ~ 230 rpm to saturation in 2 
ml of LB broth containing 50 µg ml-1 of ampicillin, flasks of 200 ml of LB broth again 
containing 50 µg ml-1 of ampicillin were inoculated and grown to an OD600 of 1.5 – 2.0 at 
37 ˚C at ~ 230 rpm. Cultures were centrifuged at 10,000 × g for 5 min at room temperature 
to obtain a pellet, and the supernatant was discarded. Pellets were resuspended in 5 ml of 
solution 1 / RNase A. Once fully resuspended the culture was transferred to a screwcap 
centrifuge tube. 5 ml of Solution 2 were added and this was mixed by inverting tubes 10 
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times to obtain a clear lysate after which tubes were left at room temperature for 1 – 2 min. 
7 ml of solution 3 were added and mixed by immediately and thoroughly inverting the tube 
until a white precipitate formed. Tubes were centrifuged at 23,500 × g for 30 min at 4 ˚C. 
4 ml of supernatant were transferred to a HiBind DNA Midi column in a 15 ml collection 
tube. The column and collection tube were centrifuged at 3900 × g for 5 min at room 
temperature and the flow through was discarded, remaining lysate was added (4 ml at a 
time) and the column centrifugation process repeated until all lysate had been passed 
through the column (again with the flow through being discarded). 3 ml of Buffer HB were 
added to the column and centrifuged at 3900 × g for 5 min at 4 ˚C, after which the flow 
through discarded. 4 ml of DNA wash buffer (diluted with ethanol as per the kit’s 
guidelines) were added to the column and centrifuged at 3900 × g for 5 min at 4 ˚C, this 
was then repeated and the flow through was discarded. The column was centrifuged a final 
time at 3900 × g for 10 min at 4 ˚C to ensure the column was empty and any traces of 
ethanol were removed. The dry column was then transferred to a sterile 15 ml centrifuge 
tube and 2 ml of elution buffer were added to the column matrix and this was left at room 
temperature for 1 – 2 min. Tubes were centrifuged at 3900 × g for 5 min at 4 ˚C and the 
purified plasmid was transferred to two sterile 2 ml tubes. 0.1 volume of 3 M NaOAc was 
added followed by 0.7 volume of isopropanol. Tubes were inverted to ensure mixing and 
centrifuged at 23,000 × g for 10 min at 4 ˚C. Following centrifugation, the supernatant was 
discarded and the pellets left to air dry for 10 min. One pellet was resuspended in 20 µl of 
sterile TE buffer and this was then used to resuspend the partner tube. Plasmid DNA 
extracts were stored at – 20 ˚C. 
7.2.1.2 Eppendorf Perfectprep kit 
E. coli pre-cultures were grown to saturation overnight in 2 ml of LB broth containing 50 
µg ml-1 of ampicillin at 37 ˚C, ~ 230 rpm. From these pre-cultures 200 ml of LB broth 
again with 50 µg ml-1 of ampicillin were inoculated and grown to an OD600 of 1.5 – 2.0 at 
which point cells were spun at 10,000 × g for 5 min at room temperature. 4 ml of ice cold 
solution 1 were used to re-suspend the pellet, the suspension was incubated at room 
temperature for 10 min followed by 5 min on ice. 4 ml of solution 2 were added to the 
suspension and gently mixed by inverting, and place back on ice for 5 min. 4 ml of ice cold 
solution 3 were added to the suspension and mixed again by inverting and placed back on 
ice for a further 10 min. The suspension was centrifuged at 23,000 × g for 30 min at 4 ˚C 
after which the supernatant was transferred to a 50 ml falcon tube. 10 ml of ice cold, well-
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mixed, DNA binding matrix were added and mixed by repeated vigorous shaking and 
inverting. A spin column was added to another 50 ml falcon tube and the matrix bound 
sample was poured into the column (the previous tube was not discarded). The column and 
its retaining 50 ml falcon tube were centrifuged at 2000 × g for 5 min and room 
temperature and the filtrate was discarded. 10 ml of purification solution (diluted with 
ethanol as per guidelines in the kit) were added to the used 50 ml falcon tube, which had 
been kept, and this was then added to the “cake” in the column. The column and its 
retaining tube were centrifuged again at 2000 × g for 5 min at room temperature and again 
the filtrate was discarded. The column was centrifuged a final time at 2000 × g to ensure it 
was dry and all suspension had passed through. The column was then transferred to a fresh 
50 ml falcon tube and 3 ml of elution buffer were added directly to the “cake” retained in 
the column. This was then spun at 3900 × g for 10 min at room temperature and the eluted 
plasmid that was collected in the falcon tube was transferred to a 12 ml centrifuge tube 
suitable for high g forces. 70 µl of 5 M NaCl and 60 µl of mussel glycogen were added to 
the elute and mixed. 6 ml of 100% EtOH were added and mixed well. This mix was then 
centrifuged at 23,000 × g for 30 min at 4 ˚C and the supernatant was discarded. A wash 
using 2 ml of 70% EtOH was repeated twice, both times at 23,000 × g for 15 min at 4 ˚C, 
the supernatant was discarded between washes. Any remaining EtOH was removed and 
pellets left to air dry for ~ 15 min. Once dry the pellet was resuspended in 25 µl of sterile 
TE buffer and stored at – 20 ˚C. 
7.2.2 Plasmid quantification 
To quantify the concentration of plasmid DNA from the extraction, plasmid DNA was 
diluted 1:10 using sterile TE buffer to a total volume of 50 µl loaded onto a Greiner 96 
well UV transparent plate (Sigma-Aldrich, # M3812) and read on the Molecular Devices 
SpectraMAX 190 plate reader (Molecular Devices, Sunnyvale, USA, model no. 190) at 
260, 280 and 320 nm. 
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7.2.3 Enzymatic digest 
A master mix was prepared (Table 7) of H2O, 10 X buffer, KpnI enzyme (10,000 units/ml) 
and BSA (20 mg/ml) (enzyme and buffer were from New England Biolabs #R0142S). 3 µl 
of plasmid extract (diluted to a concertation of 100 ng µl-1) were added to two tubes per 
sample, one to be digested and one to remain uncut to be used as a control. Once the 
contents of the tubes were mixed, tubes were placed in a water bath heated to 37 ˚C for 1 h 
after which samples were loaded onto an agarose gel. see section 7.2.4 for details. 
Table 7. The master mix preparation for enzymatic digests of extracted plasmids. 
Reagent Volume (µl) (1 prep) Volume (µl) (20 preps) 
H2O 14.30 286.00 
10 X Buffer 2.00 40.00 
KpnI Enzyme 0.50 10.00 
BSA 0.20 4.00 
Total volume (µl) 17.00 340.00 
 
7.2.4 Agarose gels 
A 1% (w/v) agarose gel was cast by dissolving agarose powder in 1 X TAE buffer using a 
microwave. Once this had cooled to ~ 55 ˚C, 0.5 µg per ml of ethidium bromide was added 
to stain the gel. Samples were prepared using 1 µl of plasmid or plasmid digest product, 9 
µl of H2O and 2 µl of 6 X loading buffer. The gel was placed in a tank filled with 1 X TAE 
buffer. Samples were loaded into the lanes along with a lane containing 5 µl of Gene Ruler 
DNA ladder 1 kb (Fermentas, Lithuania, cat. No. #SM0331) in order to size the bands that 
were detected. 
7.2.5 Sequencing and sequence alignment 
5 µl of plasmid at a concentration of 100 ng µl-1 were mixed with the 2721K primer (1 µl). 
The 2721K primer sequences were GAAAACCTGAAATTACAG with a melting temperature 
(Tm) of 44.1 ºC. Plasmids were then sequenced by DBS Genomics (Durham University, 
Durham, UK). Sequences were then aligned using BioEdit (Ibis Biosciences, Carlsbad, 
California) (Fig. 9).  
	 39	
7.2.6 Strain transformation (Gietz and Schiestl, 2007) 
A preculture of cells was grown in 2 ml of SD-U media for 48 h. An OD600 reading was 
taken and 5 ml of SD-U media per desired transformation were inoculated and grown to a 
final OD600 of ~ 1.0 (e.g. for 5 transformations 55 ml of media would be inoculated). 
Cultures were transferred to a sterile 50 ml tube and spun at 3750 × g for 2 min at 4 ˚C 
after which the supernatant was discarded and the cell pellet placed on ice. The pellet was 
resuspended in 9 ml of 1-step buffer, (1 part 0.2 M LiOAc and 4 parts 40% (w/v) PEG 
4000 (Sigma, #1546569-1G)). The cell suspension was centrifuged again at 3750 × g for 2 
min at 4 ˚C, after which again the supernatant was discarded and the pellet placed back on 
ice and left for 1 – 2 min to allow for the remaining 1-step buffer to collect at the bottom of 
the tube and be removed. 88 µl of 1-step buffer were added for each transformation 
required and an additional 88 µl to ensure sufficient cell suspension was available. The 
pellet was resuspended ensuring no clumps remained. 88 µl of suspension were added to a 
sterile 1.5 ml tube containing 12 µl of sheered salmon sperm DNA (Invitrogen #15-632-
011) (pre-boiled for 5 min in a heat block) and 1 µl of the desired plasmid and the tubes 
vortexed at maximum speed for 15 s. The plasmids were created by Dr. Sergej Šesták 
(Slovak Academy of Sciences, Bratislava, Slovakia) and sent to myself to be extracted and 
used in this work, (Fig. 6) Tubes were incubated at 42 ˚C in a water bath for 30 min before 
being briefly spun at max speed (~ 13,000 × g for 10 s at room temperature) to collect the 
pellet and the supernatant was removed. The cell pellet was resuspended in 200 µl of 
sterile H2O and the full suspension was spread on a SD agar plate with an appropriate 
amino acid dropout (dictated by amino acid synthesis gens used in the plasmid). Plates 
were incubated at 30 ˚C for ~ 5 days to allow for single colonies to grow. 
7.2.7   Replica plating and acetate testing 
To ensure that the cells grown on plates were not cells containing a mutation preventing 
growth on media containing only non-fermentable carbon source, known as petite cells, 
replica plating from the SD-dropout plates to yeast peptone acetate plates (YPAc) was 
utilised. This was achieved by placing the SD-dropout plate onto a sterile piece of velvet 
and applying gentle pressure. A YPAc plate was then placed onto the velvet and again 
gentle pressure applied allowing for the transferring of colonies. YPAc plates were then 
incubated at 30 ˚C for ~ 48 h to allow for single colonies to grow. These colonies were 
then matched to the SD-dropout plates to confirm which cells were not petites. It was these 
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non-petite cells that were streaked onto a fresh SD-L-U plate and incubated again at 30 ˚C 
for ~ 48 h to allow for single colonies to grow for use in future experiments. 
7.2.8 Cell culturing and DTT stressing for S. cerevisiae 
A sterile wooden toothpick was used to select cells from a plate containing cells of the 
appropriate strain and mutation. This toothpick was then placed into 2 ml of media (either 
YPD or SD depending on the experiment) and cultured for 48 h prior at 30 ˚C, ~ 200 rpm 
(pre-culture). For the inoculation of larger volumes, 100 µl of pre-culture were added to 
900 µl of fresh media and an optical density reading was taken at 600 nm (OD600) using a 
colour density meter (WPA, Cambridge, UK. model no. CO8000). This allowed for initial 
OD600 readings to be calculated for inoculations of larger volumes of medium. For all S. 
cerevisiae experiments cells were cultured using the same parameters. Incubation was in a 
rotary incubator with a temperature of 30 ˚C and a shaking speed of ~ 220 rpm. DTT 
stressing was achieved by the treatment of cell cultures with 2 mM of DTT dispensed from 
a 1 M stock solution (stored at – 20 ˚C when not in use).  
7.2.9 Protein extraction for western blotting analyses (Papa et al., 2003) 
PWY260 containing the required mutation carried on the YCplac33 plasmid was grown 
over 48 h in 2 ml of SD-U media (pre-culture). 105 ml of fresh SD-U media were 
inoculated and grown in a 250 ml flask to an OD600 reading of 0.3 – 0.8 (mid-log phase). 
Once the culture had grown to within the desired OD600 range 50 ml were transferred to a 
125 ml flask and treated with 2 mM of DTT. Flasks both with and without DTT were 
incubated for 2 h at 30 °C and 220 rpm. After 2 h, 50 ml of culture from DTT treated and 
untreated cells were transferred into separate, sterile 50 ml falcon tubes. Cultures were 
spun at 3750 × g for 2 min at 4 °C to separate the cells from the medium, the supernatant 
was discarded. Cells were washed with 5 ml of ice cold H2O by spinning at 3750 × g for 2 
min at 4 °C. The supernatant was discarded and the cells were washed again with 1 ml of 
ice-cold H2O. The cells were resuspended in 1 ml of ice-cold H2O and transferred into a 2 
ml screw cap tube suitable for homogenisation. Cells were spun at 12000 × g for 1 minute 
at 4 °C and the supernatant was discarded. 200 µl of lysis buffer (8 M urea, 2.5% (w/v) 
SDS, 50 mM Tris∙HCl pH 7.5 at 4 °C, 6 mM EDTA, 5 mM b-mercaptoethanol, 2 mM 
PMSF and 6 mM AEBSF) were added to the cells and around 0.5 volume of glass beads 
(Thistle Scientific, Glasgow, UK, cat. no. #11079105) were added. The cells were 
homogenised in a Precellys 24 instrument (Bertin Instruments, Montigny-le-Bretonneux, 
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France) at 6500 rpm for 3 cycles of 15 s at 4 °C. The cells were placed on ice for 5 min 
between cycles. The cells were then centrifuged at 12000 × g for 10 min at 4 °C, the 
supernatant was transferred to a fresh, sterile 1.5 ml screw cap tube and flash frozen in 
liquid nitrogen and stored at – 80 ˚C until required. 
7.2.10  Bicinchonic Acid (BCA) protein assay (Smith et al., 1985) 
To quantify how much protein was extracted a bicinichonic acid (BCA) assay was used. 
Protein lysates, BSA standards (0, 62.5, 125, 250, 500, 1000 and 2000 µg ml-1) and blanks 
were diluted 1:10 with 0.1 M 2-iodacetamide in 0.1 M Tris-HCl (pH 8.0) and incubated in 
a 37 °C water bath for 20 min, this is to destroy the b-mercaptoethanol present in the 
lysate. 10 µl of sample were added to the bottom of a U-bottom 96 well plate. 200 µl of 
working solution (Table 2.) were added to each well, the plate covered and incubated at 60 
°C for 30 min. Absorbance could then be read at 562 nm using the Molecular Devices 
SpectraMAX 190 (Molecular Devices LLC, Sunnyvale, California). These values allowed 
for the required dilutions for equal loading on the SDS-PAGE gel to be calculated. 
7.2.11  SDS-PAGE (Laemmli, 1970) 
Protein lysates were run on a 8% SDS-PAGE gel with a 1 mm spacing between the glass 
plates. The gel was made of a stacking gel and a separating gel. The composition of the 
stacking gel was 30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide (2 ml), 1M Tris·HCl, 
pH 8.9 (1.875 ml), H2O (3.603 ml), 10% SDS (50 µl), 10% ammonium persulphate (APS) 
(45 µl) and Tetramethylethylenediamine (TEMED) (10 µl). The separating gel 
composition was 30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide (340 µl), 1M Tris·HCl, 
pH 6.8 (625 µl), H2O (1.549 ml), 10% SDS (6.25 µl), 10% ammonium persulphate (APS) 
(22.5 µl) and Tetramethylethylenediamine (TEMED) (7.5 µl). These volumes were to cast 
one gel. After the addition of H2O, the solution was degassed for 5 minutes. 
 Once polymerised, samples were diluted using H2O to a concentration of 100 µg ml-1. 
Prior to loading, 20 µl of protein at 100 µg ml-1 was mixed with 4 µl of 6 x SDS-PAGE 
loading buffer. This was then heated at 70 °C for 10 min, left to cool to room temperature 
and 20 µl were loaded into the wells. A molecular weight marker (Thermo Fisher 
Scientific, Cramlington cat. no. 26616) loaded into the first lane of the gel. The gel was run 
for 2 h at 100 V in a Fisherbrand TV100 gel system. 
	 42	
7.2.12  Western blotting and chemiluminescent detection (Towbin et al., 1979) 
The gel was removed from the electrophoresis unit and the stacking gel removed. The 
separating gel was placed in semi-dry electrotransfer buffer for 30 min at 50 rpm at room 
temperature. A PVDF membrane (GE healthcare, Little Chalfont, Buckinghamshire, UK 
cat. no. 10600021) was cut to the size of the gel with an additional ~ 10% in both 
dimensions and soaked in 100% methanol for 10 min followed by 30 min in semi-dry 
electrotransfer buffer. 8 pieces of Whatmann 3 MM paper were cut to the size of the gel, 
with an additional ~ 10% in both dimensions, and soaked for 10 min in semi-dry 
electrotransfer buffer. Once all the components were prepared they were stacked onto the 
semi-dry horizon blot system (Atto, East Sussex, UK, Model #AE-6675L). The stacking of 
the components first involved the wetting of the anode and cathode plates of the blot 
transfer system with semi-dry electrotransfer buffer. 4 pieces of Whatmann paper were 
stacked onto the cathode with air bubbles removed from between each piece by rolling a 
glass tube over the stack with gentle pressure. The PVDF membrane was then placed over 
the Whatmann paper followed by the SDS-PAGE gel. Again, any air bubbles were 
removed as above. The final 4 pieces of Whatmann paper were stacked on top of the gel 
and again air bubbles were removed. The blot system was then closed to allow for transfer. 
The transfer was performed with a constant current of 2 mA/cm2 of membrane for 1 h and 
15 min. Once transferred, the membrane was stored in 5% milk-TBST at 4 °C on a shaker 
at 35 rpm for a minimum of 1 hour, ideally overnight.  
The proteins were detected using specific antibodies. The appropriate antibodies were 
selected depending on the protein of interest. Antibody information can be found in Table 
6. The membrane was incubated on a roller mixer at room temperature in 3 ml of 5% milk-
TBST containing the appropriate primary antibody at an appropriate dilution (Table 6.) for 
1 h. After incubation, the membrane was washed 4 times in 50 ml TBST at 50 rpm for 5 
min each wash. The membrane was incubated as before with the appropriate secondary 
antibody with appropriate dilution (Table 6.), again the membrane was washed in TBST as 
above.  
To detect the tagged proteins on the membrane a choice between two detection reagents 
was made, for lower amounts of loaded protein (< 10 µg) ECL2 (Pierce Thermo Fisher 
Scientific, UK, cat. no. 32132) was used. For higher amounts of loaded protein ( > 10	µg) a 
detection reagent of 5 ml Tris·HCl pH 8.5 + 0.1% (v/v) Tween 20, 25 µl 250 mM luminol 
(Schneppenheim et al., 1991), 11.1 µl 90 mM p-coumaric acid and 1.45 µl 30% H2O2 was 
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used, or ECL (Pierce Thermo Fisher Scientific, Cramlington, UK, cat. no. 32106). 1 ml of 
the selected detection reagent was applied and allowed to develop at room temperature for 
5 min. 
Films were exposed to Thermo-Scientific CL – X-Posure X-ray film (Thermo Fisher 
Scientific, Cramlington, UK, cat. No. 34091.) for varying exposure times, from 30 s to 5 
min, this was completed in a dark room. Films were developed using the Xograph 
Compact X4 (Xograph imaging systems, Stonehouse, UK). 
7.2.13  Stripping of western blots 
The PVDF membrane was washed in 50 ml 100 mM Tris·HCl + 0.1% (v/v) Tween 20 pH 
8.5 for 5 min. The membrane was then incubated in 50 ml 100 mM Tris·HCl + 200 mM b-
mercaptoethanol + 0.1% Tween 20 pH 8.5 for 15 min, this incubation was repeated with 
50 ml of fresh 100 mM Tris·HCl + 200 mM b-mercaptoethanol + 0.1% Tween 20 pH 8.5 
wash buffer, again for 15 min. The membrane was then washed twice in 50 ml of TBST at 
room temperature for 5 min. The membrane was then incubated twice at 37 ˚C for 15 min 
for each incubation in 100 mM glycine·HCl + 0.1% Tween 20, pH 2.5. Following this, the 
membrane was washed twice in 50 ml of TBST at room temperature for 5 min for each 
wash. Following this final wash, the membrane was placed in 5% milk + TBST and stored 
at 4 ˚C. Following stripping, the membrane could be re-probed with new antibodies if 
required. 
7.2.14  Densitometric analysis 
Densitometric analysis of the western blots exposed to X-ray film was completed using the 
ImageJ software (Public software developed at the National Institutes of Health, USA). 
Each band was selected in the software and its densitometry calculated by the software. 
Each of the Ire1 bands were standardised against the actin loading control bands for that 
lane on the gel. 
7.2.15  Protein extraction for b-galactosidase assays 
PWY260 containing the required mutation carried on the YCplac33 plasmid was grown 
over 48 h in 2 ml of SD-U medium (pre-culture). 55 ml of SD-U media were inoculated 
using the pre-culture and cells were grown to an OD600 of 0.3 – 0.8 (mid-log phase). Once 
within this range a 15 ml sample from each culture were taken, spun at 3750 × g for 2 min 
at 4 °C, the supernatant was discarded and the pellet flash frozen in liquid nitrogen and 
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stored at – 20 °C. The remaining culture was treated with 2 mM of DTT from a 1 M stock, 
and further 15 ml samples taken at 1 h and 2 h time points, pellets were collected and 
frozen as before. Once pellets for all time points were collected the frozen cell pellets were 
thawed and placed on ice. 1 ml of sterile H2O was added to each tube and the pellet re-
suspended. All of the cell suspension was transferred to a 2 ml flat-bottom screw cap tube. 
Tubes were centrifuged at 12000 × g for 1 min at room temperature and the supernatant 
was removed. The tubes were centrifuged again at 12000 × g for 1 min at room 
temperature and any remaining supernatant was removed. 100 µl of ice-cold Reporter 
Lysis Buffer (RLB) were added to each sample and pellets re-suspended by vortexing. ~ 
150 mg of glass beads (Thistle Scientific, #11079105) were added to each tube and the 
tubes homogenised in the Precellys 24 instrument at 6500 rpm for 3 cycles of 10 s, a 5 min 
break was taken between each cycle during which time the samples were placed on ice. 
Following homogenisation 100 µl of ice cold RLB buffer were added to each sample and 
each tube was briefly vortexed. Samples were centrifuged at 12000 × g for 2 min at 4 °C 
to separate the supernatant which contained the protein. This supernatant was removed and 
placed in a screwcap tube suitable for cryo-storage. Protein lysate samples were flash 
frozen in liquid nitrogen and stored at – 80 °C.   
7.2.16   DC protein assay 
To quantify the total amount of protein in the lysate a DC assay (Bio-Rad, Hemel 
Hempstead, UK, cat. no. #500-0113 and #500-0114) was run. A BSA protein standard was 
prepared in H2O with concentrations of 62.5, 125, 250, 500, 1000 and 2000 µg ml-1, and 5 
µl was added to a U-bottomed well (one well per standard). A 1:10 dilution (diluted in 
H2O) of lysate was prepared of which 5 µl was added per well. 25 µl of DC assay reagent 
A (Bio-Rad #500-0113) were added to wells containing either the standard or the lysate 
followed by 200 µl of DC assay reagent B (Bio-Rad #500-0114). The plates were left at 
room temperature for 15 min after which the absorbance was read at 750 nm using the 
Spectramax 190 plate reader. 
7.2.17 b-galactosidase assay (Miller, 1972; Schenborn and Goiffon, 1993) 
To test the levels of b-galactosidase activity and therefore the expression of UPRE-
associated genes the b-galactosidase reporter assay kit (Promega, Table 4.) was used. 1 µl 
of 1 U µl-1 of b-galactosidase was added to 99 µl of ice cold reporter lysis buffer (RLB), 
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mixed and placed on ice to create the 1:100 dilution. 10 µl of this 1:100 dilution were 
added to 900 µl of ice-cold reporter lysis buffer (RLB) to make a 1:10,000 dilution. A 
standard range was created of 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5 and 5.0 mU of b-
galactosidase. Standards were diluted where appropriate in RLB. The appropriate volume 
of RLB was added to each well, followed by the required volume of sample to a total 
volume of 50 µl. 50 µl of 2X assay buffer (200 mM NaxH3-xPO4 (pH 7.3), 2 mM MgCl2, 
100 mM b-mercaptoethanol, 1.33 mg ml-1 2-nitrophenyl-b-D-galactopyranoside) were 
added to each well and the plate covered with parafilm and incubated at 37 °C for 30 min. 
Following incubation, 150 µl of Na2CO3 were added to each well to stop the reaction. The 
plate was then read on the Spectramax 190 plate reader at 419 nm.  
7.2.18  Spotting assays 
SD-U plates were used to spot WT, empty vector and mutants of the PWY260 and Y01907 
strains. A pre-culture was grown in 4 ml of SD-U media at 30 °C at 220 rpm for 48 h and 
an OD600 reading was taken. Cells were diluted using fresh SD-U medium to the lowest 
recorded OD600 reading to ensure that equal numbers of cells were loaded to each plate for 
each mutant. DTT or tunicamycin (Tn) were used as ER stressors in increasing 
concentrations of 0, 1.5, 2.0, 3.0 and 4.0 mM DTT and 0, 0.2, 0.5, 1.0 and 2.0 µg/ml of 
tunicamycin.Samples were serially diluted from an undiluted culture down to a factor of ×10-5 of cells present in the undiluted culture. 3 µl of each dilution were spotted onto 
plates. Plates were incubated at 30 °C for 72 h before being photographed using the 
Enduro GDS Touch image capture system by Labnet (Windsor, UK, model GDS-1302) 
with an exposure time of 10 ms. 
7.2.19  Cell culture for fluorescence microscopy 
Cells were grown in 2 ml preculture in SD-L-U, containing increased concentrations of 
tryptophan and adenine sulphate (100 mg/l). 15 ml of the same media were inoculated with 
an initial OD600 of 0.05 and grown overnight at 30 °C at 220 rpm. Cells were harvested 
after overnight growth by centrifugation at 3750 × g for 2 min at room temperature. Cell 
pellets were then re-suspended in 1 ml of SD-L-U medium (as described above) and 
transferred to a 1.5 ml Eppendorf tube and centrifuged at 13,000 × g for 15 s at room 
temperature. The supernatant was removed and the pellet re-suspended in 250 µl SD-L-U 
media. In the case of stressed cells, DTT was added (2 mM concentration) to the re-
suspended pellet at this point. 5 µl of cell suspension were placed on a glass slide and the 
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cover slip attached and sealed using nail polish. Slides were imaged using the Zeiss LSM 
880 with Airyscan confocal inverted light microscope (Zeiss Ltd, Cambridge, UK). Details 
of system parameters can be found in Fig. 7. 
7.2.20 Microscopy analysis 
The microscope was set up using a two-channel approach to detect the GFP signal and the 
mCherry signal. For Sec63-GFP signal the Ch1-T1 (photomultiplier tube) channel was 
used with an excitation wavelength of 488 nm, an emission wavelength of 531 nm and a 
detection wavelength of 498 – 564 nm. For the IRE1-mCherry signal the Ch2 GaAsP-T2 
(gallium arsenide phosphide detector) channel was used with an excitation wavelength of 
594 nm, an emissions wavelength of 611 nm and a detection wavelength of 694 – 754 nm. 
The GaAsP channel was used as it has the increased sensitivity required for the signal 
detection of IRE1-mCherry. The objective lens used was the Plan-Apochromat 63x/1.4 Oil 
DIC M27 using the MDS 488/594 beam splitter. The 488 nm laser was used at a power of 
5 – 8% and the 594 nm laser at a power of 28 – 40% to optimise image quality. Gain 
settings of 650 – 900 were used, again to maximise image quality and to reduce any 
background noise. Microscope settings are presented in Fig. 7 and were reused for each 
image capture. 
 
 
Fig. 7 Settings of the Zeiss LSM 880 with Airyscan microscope. For each mutant, 
these settings were reused. 
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7.2.21 Zen Blue lite image presentation 
Images captured using the Zeiss 880 Airyscan confocal laser scanning microscope were 
edited for presentation and file format conversion using the Zen blue lite 2.1 software 
(Zeiss Ltd, Cambridge, UK). The pseudo-colour for each channel was set to the best linear 
fit recommended by the software and scale bars added to each channel. This scale bar was 
used in figure preparation to ensue all images were scaled to the same size using the 5 µm 
scale bar as a reference. The images were saved and exported as JPEG files of the 
individual channels and the original data were kept. 
7.2.22  Statistical analysis 
Data from repeats of experiments (western blots, protein assays and b-galactosidase 
assays) were compiled and averages were calculated in Prism 7 software by GraphPad 
Software, Inc. (La Jolla, California). It was from these averages (mean) that the standard 
error of the mean (SEM) values were calculated, again in Prism 7. For all data where 
statistical analysis has been completed, the error bars are representative of SEM. To 
determine statistical difference (p < 0.05) between means of data sets a 2-way ANOVA 
test was used. The parameters of the test included the use of a Tukey test to correct for 
multiple comparisons using statistical hypothesis testing. A multiplicity adjusted p value 
was reported for each comparison, the adjustment was to account for multiple 
comparisons. A confidence level of 0.05 was used. As the ANOVA test assumes equal 
variance. b-galactosidase reporter data was logged using a natural base (ln). This was 
because the values gathered across the three repeats of b-galactosidase assays had unequal 
variances, tested using the Brown-Forsythe test in Microsoft Excel. 
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8.0  Results 
8.1 Characterising the effects of ER stress on expression levels of IRE1 
8.1.1 Rationale  
To determine how IRE1 expression in mutants was influenced by ER stress a biochemical 
approach was used. This is of interest as Ire1 is a ER stress response protein and the 
induction of ER stress in the differing a-loop mutants may affect IRE1 expression 
differently. Additionally, it is important to confirm that the mutants are able to express 
IRE1 from the plasmid, as a lack of expression would be detrimental to UPR activation and 
tolerance of ER stress (Cox et al., 1993; Morl et al., 1993). The plasmid contains an IRE1-
HA gene which is critical to this experiment. The production of HA-tagged proteins by the 
cells allows for protein specific targeting utilising anti-HA antibodies (see materials and 
methods, Table 6). This means that by using the appropriate antibodies Ire1 protein can be 
detected through western blots. To quantify the relative levels of Ire1 a loading control was 
used. b-actin was chosen as it does not change expression with ER stress and should be 
uniform across mutants. Again, this can be detected using appropriate antibodies (Table 6) 
and using densitometric analysis the levels of Ire1 could be standardised against the levels 
of b-actin detected. Any increase in b-actin would indicate uneven loading of the gel. Prior 
to western blotting, the YCplac33 plasmid required transforming in PWY260 strain S. 
cerevisiae. YCplac33 was extracted from E. coli, enzymatically digested and the plasmid 
sequenced to ensure the correct mutations were present on the plasmid. Once confirmed 
the cells could be transformed with YCplac33 and the investigation into Ire1 levels 
completed. 
8.1.2 Enzymatic digest results  
Plasmids containing the a-loop mutations within the IRE1 gene were extracted from the E. 
coli in which they were expressed (see materials and methods). These plasmids were 
digested using the KpnI restriction enzyme (see materials and methods). This digest would 
confirm the plasmid by the production of three fragments of predicted sizes using the 
plasmid sequence information. Once digested, plasmids were run on a 1% agarose gel 
alongside uncut plasmid extract to view the fragments (Fig. 9). This was completed for the 
YCplac33 plasmid for use in b-galactosidase assays due to the incorporation of the UPRE-
associated LacZ reporter and pEvA97 plasmid for use in fluorescent microscopy due to the 
incorporation of IRE1-mCherry. 
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Fig. 8 Agarose gels of the plasmid extract and digested plasmid product of the 
YCplac33 plasmid (A) and the pEvA97 plasmid (B). In both cases the digested 
plasmid was cut into three fragments (this is less obvious on gel A however the 
additional two fragments can be seen towards the bottom of the gel). Digested 
products in both cases were produced through incubation with the KpnI enzyme, 
presence of the enzyme is indicated by the - / + above each lane.  
KpnI 
KpnI 
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The fragments allowed for the sizing of the plasmid. YCplac33 is 10,569 bp in length, Fig. 
8 A shows a band in the lane containing the digested product at around 6000 bps, a second 
band at around 2500 bp and a third at around 1500 bp, totalling around 10,000 bp. pEvA97 
(Fig. 8 B) is 11,684 bp in length and shows bands of sizes around, 4300 bp, 4200 bp and 
2800 bp, totalling around 11300 bp. In both cases, digestion of plasmid produced bands of 
lengths expected by the use of this plasmid and restriction enzyme. Due to the supercoiled 
nature of the undigested plasmids they do not migrate at the correct positions on the 
agarose gel as the coiled plasmid travels further down the gel.  
8.1.3 Plasmid sequencing results 
Following the digest of the plasmids and confirmation on the agarose gel, the plasmids 
were sent for sequencing using the 2721K primer. After confirming the plasmid was 
successfully extracted it is important to validate that the correct mutations were present in 
the nucleotide sequence, resulting in the change of the native amino acid to an alanine. 
Following sequencing (see materials and methods), the newly acquired nucleotide 
sequences were added to the BioEdit software and sequence alignment was completed 
(Fig. 9). At the sites where the sequence did not match the WT, the change was 
investigated. This was to confirm that the native amino acid residue seen in the WT was 
being changed to an alanine in the correct position in the IRE1 gene on the plasmid and not 
another mutation. To give an example from Fig. 9 and Table 8 below, the WT at positions 
7725 – 7727 in the sequence has a codon of GAC which codes for aspartic acid (the D836 
residue to be exact). The sequence below the WT is of D836A which at the same position 
has a codon of GCT which codes for alanine (D836A). This confirmation was carried out 
for each plasmid that was sequenced. In the case of D836A-P-A a different codon is used 
from the single D836A mutant. This was not considered an issue providing the correct 
amino acid was coded for. In this case, GCC also codes alanine. Changes to the 
nucleotides at all the residues used in this work are in Table 8. The relative positions of 
these mutations can be seen in Fig. 2.  
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Fig. 9 An example of the sequence alignment used, in this case showing the 
pEvA97 plasmids using the BioEdit software. The coding sequence was compared 
to that of the WT to ensure the expected mutations were present and that the 
change to the coding sequence was correct.  
Table 8. pEvA97 plasmid mutants. This table shows the reading frame of the 
sequences and the changes made to the nucleotide sequence create the desired 
mutant. The analysis of the changes to the sequence shown here illustrate how 
the differences in sequence alignment in the BioEdit software were validated (Fig. 
9). Fig. 2 highlights the mutations included in Q-A and P-A mutants. 
 
Once the plasmids had been aligned and mutations confirmed PWY260 and MSY14-02 
cells were transformed with the plasmids, (see materials and methods and Fig. 6). 
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8.1.4 Western blot results 
The mutants created through the transformation of PWY260 cells with YCplac33 required 
testing to ensure expression of the Ire1 present on the YCplac33 plasmid. This utilised the 
HA tag present on plasmid encoded IRE1. It was of interest to know if cells would attempt 
to compensate for a lack of Ire1 capable of accepting phosphates to the a-loop by 
producing more Ire1 to attempt to rectify inefficient UPR activation of Ire1 phospho-
mutants and elevate the ER stress. Additionally, it is important to ensure that mutants 
behave as close to the WT in terms of levels of Ire1 protein production as possible. This 
will ensure that any reduction in UPR activation in these mutants is not simply an artefact 
of reduced Ire1 protein levels in cells whilst under ER stress, when compared to the WT. 
Proteins were extracted from cells during their mid-log phase. After 100 µg of the proteins 
were separated on an 8% SDS-PAGE gel, they were transferred onto PVDF membranes 
and blotted for Ire1-HA and the actin loading control (Fig. 10 A) as described in materials 
and methods. Following blotting and exposure to X-ray film the bands were subjected to 
densitometric analysis using ImageJ software. (Fig. 10 B). 
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Fig. 10 Representative blot data for a-loop mutants. (A) Western blot for Ire1-HA 
(~ 127 kDa) and b-actin as a loading control (MW ~ 35 kDa). This blot used 100 µg 
of protein lysate and ECL as the detection reagent. (B) Densitometric analysis of 
blots was completed using ImageJ. Induction of Ire1 with ER stress can be seen 
with a minimum of ~ 2-fold change in all mutants when compared to the 
unstressed wild type, (ER stress induced using 2 mM DTT). Between the mutants 
and WT under the same ER stress conditions, no statistical difference was 
calculated. Relative Ire1 was measured against b-actin as a loading control and 
fold change was calculated by standardising against WT under no DTT stress. The 
error indicated is the standard error of the mean across three repeats. 
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Fig. 10 (A) shows that with 2 mM DTT treatment an increase Ire1 expression was 
observed in all mutants and the WT. Fig. 11(B) shows that in all cases the increase in Ire1 
expression is ~ 2.0 - 4-fold, when compared to WT under no ER stress. D836A-P-A shows  
~ 6.5-fold increase in detected Ire1 when compared to the untreated WT, however, it can 
be seen that the standard error of the mean (indicated by the error bars) is the largest for 
this sample. It was found that there is no statistical difference using a 2-way ANOVA test 
between different mutants under the same stress conditions when compared to the WT. 
This is important as it suggests that in all mutants, there is no difference in relative Ire1 
expression levels with the introduction of ER stress when compared to the WT. In terms of 
the UPR, this suggests all mutants are equally capable of Ire1 protein expression and they 
all induce this expression at levels seen in the WT. In an experiment designed to 
investigate the role phosphorylation plays in relation to RNase activity of Ire it is important 
to ensure that all the mutants express Ire1 protein effectively and that this expression is 
comparable to the WT under stress conditions. Here, the data suggest that the induction of 
IRE1 and the levels of Ire1 protein from the WT and mutants under both stressed and non-
stressed conditions is comparable. This means that the increase or decrease or decrease in 
HAC1 mRNA splicing seen in Fig. 5 is not resulting from varying Ire1 levels across the 
mutants. 
8.2 Characterising the effects of mutations within the a-loop on the induction of an 
UPRE-b-galactosidase reporter   
8.2.1 Rationale 
The retention of some level of RNase activity by mutants that lack phospho-acceptor 
residues within the a-loop of Ire1 (Fig. 5) presented the question of, is there a 
compensatory system in place for the activation of the RNase domain of Ire1 in the event 
of a loss of phospho-acceptor? A likely candidate was deemed to be the D836 residue 
within the a-loop based on its negative charge and a possible ability to mimic the 
interactions of the phosphorylated a-loop. Additionally, should the D836 residue provide a 
basic level of RNase activation, then would the mutation of this residue to D836A result in 
a phenotype when compared to the WT? Furthermore, if the hypothesis that D836 can 
compensate for loss of phosphorylation of the a-loop is true, does this compensation affect 
different phospho-mutants to the same extent? To characterise the role of D836 and the 
effect of phospho-acceptor site mutations within the a-loop and how these affect the 
activation of the UPR, activation was measured using a UPRE-associated-b-galactosidase 
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reporter assay. Should the D836 residue allow for a bypass of the phospho-acceptor 
residues within the a-loop then UPR-activation should not be exhibited in phospho-mutants 
containing a D836A mutation.  
b-galactosidase is an enzyme that catalyses the hydrolysis of b-galactosides such as the 
ortho-nitrophenyl-b-galactoside (ONPG) contained within the 2X assay buffer used in this 
assay. The reporter is constructed so that the E. coli gene lacZ (which encodes b-
galactosidase) uses the promoter of the UPR-induced gene KAR2 which displays increased 
expression under ER stress (Kohno et al., 1993). As ER stress induces the UPR, KAR2 is 
expressed, due to the UPRE within its promoter, and consequently lacZ is also expressed. 
The b-galactosidase produced cleaves ONPG producing galactose (colourless) and o-
nitrophenol (yellow) allowing for a measure of colour change (measured at 419 nm) 
indicative of reporter activity, see materials and methods. The UPR-associated gene KAR2 
requires mature HAC1 mRNA to be translated to activate expression (Mori et al., 1992; 
Kohno et al., 1993; Kimata et al., 2003; Montenegro-Montero et al., 2015), therefore the 
RNase domain must be activated to splice HAC1 mRNA to produce this mature product. 
To combine all of this, a stronger colour change suggests a stronger induction of UPRE-
associated genes, suggesting stronger RNase activation and UPR-activation.  The detection 
of both spliced and unspliced HAC1 mRNA in northern blots (Fig. 5) is sufficient to 
indicate the presence of mRNA in the sample however to elevate ER stress, the UPR 
utilises proteins. It has been shown in a global analysis of protein expression in yeast that 
the concentrations of many proteins within a cell are not predictable by mRNA levels 
(Ghaemmaghami et al., 2003). The use of a UPRE-associated reporter assay allowed for 
investigation of the UPR protein expression activity induced by Ire1 ER stress signalling 
through the activity of an associated reporter. To quantify this response, the quantity of b-
galactosidase was standardised against total protein content calculated from DC assays. 
This gave mU of b-galactosidase per mg of total protein. The WT and empty vector 
(negative) cells served as baselines to which the activation of the UPR in all mutants could 
be compared. Additionally, the mutants containing a D836A mutation were compared to 
phosphorylation mutants which contained the native D836. If indeed D836 is playing a 
compensatory role, then the residual UPR activation should be completely halted with the 
inclusion of the D836A mutation to phospho-acceptor site mutants. As the concentration of 
b-galactosidase reduces dramatically in the event of a-loop phospho-acceptor site 
mutation, to analyse the b-galactosidase data values were logged using the natural log base 
	 56	
(ln) allowing for 2-way ANOVA analysis to be completed. The data are logged for 
ANOVA because the data are heteroscedastic, which violates the ANOVA assumption of 
homoscedastic data, this was confirmed with the use of a Brown-Forsythe test.  
8.2.2 b-galactosidase reporter assay results 
To assess reporter activity 15 ml samples were taken at the 0 h time point and compared 
with 15 ml samples after 2 h of exposure to 2mM DTT. It was found that the extent of the 
reduction in phospho-acceptor residues affected levels of attenuation in UPR activation 
observed in the assay. The S840A-S841A mutant seemed to suffer the least attenuation, 
with P-A having the highest and Q-A the middle level (Fig. 11). This suggests that with an 
increase in the number of mutations to phosphorylation sites within the a-loop comes an 
increased attenuation in the UPR indicated by reporter activity. The S837 residue and its 
role in ER stress response has not previously been documented experimentally. The data 
presented here show that a mutation at this site negatively impacts on the reporter activity 
suggesting a reduction in the effectiveness of the UPR. The Q-A mutant and the P-A 
mutant are identical apart from P-A includes S837A. The data show that the P-A mutant, 
which includes S837A, shows less reporter activity than that shown by the Q-A mutant 
(Fig 11 and Table 9), suggesting that the S837 residue is involved in the activation of Ire1. 
When the reporter activity of the S840A-S841A, Q-A and P-A mutants was compared to 
the empty vector negative control it was found that in all cases there was a statistical 
difference (2-way ANOVA). This implies that a level of ER stress response is retained, as 
the empty vector should serve as a baseline for no Ire1 activity. 
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Fig. 11. Compiled data from three repeats of the b-galactosidase reporter assays 
show that the more extensive phospho-acceptor mutants have a more diminished 
ER stress response (A). The S840A-S841A mutant retains the highest level of 
UPRE-associated reporter expression, indicated by reporter activity. The Q-A 
mutant, with the S837 residue remaining shows the next highest levels of reporter 
activity when compared to the WT. The inclusion of the S837A mutation in the P-A 
mutant reduces activity the most when compared to the WT. The inclusion of the 
D836A mutation to the phospho-mutants reduces ER stress response to levels 
seen in the empty vector (Neg), confirmed with 2-way ANOVA statistical analysis. 
Next the D836 residue was investigated to determine if it is providing a level of 
compensatory Ire1 activation in the event of a loss of phosphorylation capability within the 
a-loop. To investigate this, first the WT was compared with an empty vector negative 
control and the D836A mutant (Fig. 12 panel A). The data show that the mutation of the 
D836 residue within the a-loop alone, as this mutant still possesses a-loop phosphorylation 
capacity, does not attenuate expression of the lacZ reporter and by extension KAR2 which 
implies RNase activation and UPR activation. When compared statistically using a 2-way 
ANOVA, no difference was observed between the WT and D836A mutant in data gathered 
from three repeats (Table 9) indicating that the D836 residue does not play a primary or 
indispensable role in RNase activation on its own. Next the effect of combining the D836A 
mutation with the phosphorylation site mutations was investigated (Fig 12 panels B, C and 
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D). This is presented alongside the data for phosphorylation residue mutants without the 
D836A mutation. The data show that in all cases there is significant reduction in the 
activation of the reporter and when compared to the WT, (analysed using 2-way ANOVA, 
information in Table 9.) The inclusion of the D836A mutation to the S840A-S841A, Q-A 
and P-A phospho-mutants eliminates the residual activity detected in phospho-mutants 
(Fig. 11). To analyse the level of this further attenuation, a two-level statistical analysis 
approach was taken. Firstly, it was assessed if the inclusion of D836A produced a 
significantly different (p < 0.05) result from the phospho-acceptor mutants lacking D836A. 
This was shown to be true for S840A-S841A and Q-A mutants (Fig. 12). When D836A 
was included in these two mutants there was statistical difference calculated (Table 10) 
using a 2-way ANOVA. The same statistical difference was not seen in the P-A vs. 
D836A-P-A test (Fig. 12 D). This may be due to the highest reduction in b-galactosidase 
reporter activity being in the P-A mutant when compared to the WT (Fig. 11). Since the P-
A mutant had the lowest recorded reporter activity this could explain why the difference 
between the P-A and D836A-P-A mutant may not be significant, as the P-A mutant is 
already at such a low level the ANOVA test may be unable to determine a statistical 
difference between the means of the data sets and would require a higher number of 
repeats than the three used here. 
The next statistical comparison made was between the D836A-phospho-acceptor mutants 
and the empty vector. This allowed for it to be determined if the inclusion of D836A 
eliminated the residual ER stress response or if it simply attenuated the response further. It 
was found that there was no statistical difference (2-way ANOVA) between the D836A-
S840A-S840A, D836A-Q-A and D836A-P-A mutants when compared to the empty vector 
(Neg) (Table 9) suggesting that the reduction in ER stress response was absolute.  
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Fig. 12 Complied data from three repeats of the b-galactosidase assays. These 
data were subject to a 2-way ANOVA test to determine statistical difference (p < 
0.05) using all data. This analysis showed that there were statistical differences 
when the means were compared between S840A-S841A and D836A-S840A-
S841A mutants as well as between Q-A and D836A-Q-A mutants. WT and empty 
vector (Neg) data is repeated data in each panel however is compiled from three 
repeats.  
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Table 9. The p values calculated from the 2-way ANOVA between WT and the 
mutants and the empty vector (Neg) and the mutants. It was found that when 
compared to the WT all the phospho-acceptor mutants were statistically different. 
This was also the case with phospho-acceptor mutants containing D836A 
mutations. Importantly there was no statistical difference between WT and the 
D836A mutant. When compared to the negative control, the phospho-acceptor 
mutant differences were all statistically significant, however, with the inclusion of 
the D836A in these mutants showed no significant difference when compared to 
the negative control. 
Tukey's multiple comparisons test Significant Adjusted P Value 
WT vs. Neg Yes < 0.0001 
WT vs. D836A No > 0.9999 
WT vs. S840A-S841A Yes 0.01 
WT vs. D836A-S840A-S841A Yes < 0.0001 
WT vs. Q-A Yes < 0.0001 
WT vs. D836A-Q-A Yes < 0.0001 
WT vs. P-A Yes < 0.0001 
WT vs. D836A-P-A Yes < 0.0001 
Neg vs. D836A Yes < 0.0001 
Neg vs. S840A-S841A Yes < 0.0001 
Neg vs. D836A-S840A-S841A No > 0.9999 
Neg vs. Q-A Yes 0.0005 
Neg vs. D836A-Q-A No 0.9974 
Neg vs. P-A Yes 0.0238 
Neg vs. D836A-P-A No 0.8544 
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Table 10. Statistical comparison using 2-way ANOVA between the a-loop 
phospho-acceptor mutants and a-loop phospho-acceptor mutants containing 
D836A. 
Tukey's multiple comparisons test Significant? Adjusted P Value 
S840A-S841A vs. D836A-S840A-S841A Yes < 0.0001 
Q-A vs. D836A-Q-A Yes < 0.0001 
P-A vs. D836A-P-A No 0.7118 
 
8.2.3 D836 plays a role in Ire1 stress signal transduction 
In all b-galactosidase assay experiments, the D836A mutant exhibited the same levels of 
UPR activation as the WT with no statistical difference in any of the repeats (Fig 12 A and 
Table 9). However, with all mutants containing a-loop phospho-acceptor mutations there is 
an attenuation of reporter activity in the assay suggesting that UPR activation is reduced 
(Fig. 11 A). This lack of ER stress response may be because of reduced RNase activation 
in phospho-acceptor site mutants. This is because it is thought that phosphorylation of the 
a-loop plays a role in RNase activation through the stabilisation of an oligomer-compatible 
conformation (Korennykh et al., 2009), or through activation of the kinase domain (Lee et 
al., 2008) possibly by interacting with catalytic sites within the kinase domain (Johnson et 
al., 1996; Knighton et al., 1991; Nolen et al., 2004). The increase in the number of 
phosphorylation site mutations in S840A-S841A, Q-A and P-A mutants corresponds to a 
reduction in the levels of b-galactosidase reporter activity (Fig. 11 A). Maximum retention 
of reporter activity was observed in the S840A-S841A mutant, which still possesses 
phosphoserine at positions 837 and 850 and phosphothreonine at 844. Whereas the 
minimum reporter activity was measured in the P-A mutant which possesses no phospho-
acceptor sites within the a-loop. In the cases of the D836A-S840A-S841A, D836A-Q-A, 
and D836A-P-A mutants, no statistical difference was observed between the D836A-
phospho-mutants and the empty vector (Table 9). These data suggest that D836 plays a 
role in the ER stress response. Furthermore, that the level of the UPR activation, when 
reliant on D836, is influenced by phosphorylation of the S837, T844 and S850 residues. 
This also suggests that the S837, T844 and S850 resides are not capable of producing an 
ER stress response signal without the D836 residue. If these residues could produce an ER 
stress response the D836A-S840A-S841A mutant would have retained levels of reporter 
activity facilitated by the phosphorylation of S837, T844 and S850 and induction of the 
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UPR. This was not the case (Fig. 11 B), it was observed that in the D836A-S840A-S841A 
mutant b-galactosidase reporter activity was reduced to level of the empty vector (Fig. 12 
B). Furthermore, this supports the notion that the S840 and S841 residues may play the 
role of primary phosphorylation sites within the a-loop (Nolen et al., 2004), and the S840 
and S841 residues, perhaps working in tandem, are the primary phosphorylation residues 
(Shamu and Walter, 1996) as the D836A single mutant was unaffected in terms apparent of 
Ire1 activation. The shows that S840 and S841 does not require D836 to activate Ire1 
through phosphorylation, contrary to the S837, T844 and S850 mutants. 
To summarise, when phosphorylation within the a-loop is not possible D836 seems to be 
able to facilitate a reduced level of Ire1 activation. This compensatory system seems to 
allow for partial or complete loss of phosphorylation activity within the a-loop while still 
allowing for reduced levels of ER stress signal transduction. Should the phosphorylation of 
S837, T844 or S850 be possible, then the ability of D836 to mount this induction is 
maximised. The observation of different levels of reporter activity in the different 
phospho-mutants and the elimination of residual reporter activity in D836A-inclusive 
phospho-mutants prompted the investigation of ER stress tolerance of the mutants in vivo 
using spotting assays.  
8.3 Evaluating the effect of a-loop mutations on ER stress tolerance and survival 
8.3.1 Rationale 
The UPR is known to be involved in ER stress tolerance, which promotes survivability of 
ER stress (Jäger et al., 2012). A reduced UPR activation should therefore result in reduced 
ER stress tolerance. To assess if the reduction in the ER stress response observed in the b-
galactosidase assays translated into reduced survivability of ER stress in vivo, spotting 
assays were used. Spotting assays allow the survivability of ER of the mutants to be tested 
when grown on medium containing an ER stressor, in this case increasing concentrations 
of DTT and tunicamycin (Tn). Cells were serially diluted and spotted onto the DTT and Tn 
plates (see materials and methods). Stressing cells with mutations at a-loop 
phosphorylation sites thought to be crucial to UPR activation should highlight any 
deficiencies in ER stress survivability. It is of interest as to whether the more extensive 
mutants (Q-A and P-A) suffer with more reduced ER stress tolerance when compared to 
the less extensively mutated S840A-S841A and D836A mutants. Again, the inclusion of 
D836A to the phospho-acceptor mutants will allow for the role D836 plays in ER stress 
response to be characterised. When compared to the WT it was expected that the S840A-
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S841A, Q-A and P-A mutants should show a reduction in ER stress tolerance manifested 
by a reduction in growth under ER stress. The D836A-S840A-S841A, D836A-Q-A and 
D836A-P-A mutants were expected to suffer an even larger reduction in ER stress 
tolerance that that seen in the other phospho-mutants. This was expected following the 
observations made in the b-galactosidase reporter assays. Mutants with and without the 
D836A mutations were spotted next to each other to visualise the impact of D836 on ER 
stress tolerance and survivability of ER stress. The spot on the far left of each row at each 
concentration, is the undiluted cells (all standardised to the lowest recorded OD600 value, 
see materials and methods). Each spot to the right reduces in the number of cells initially 
spotted by 10-fold to a final dilution of 10-5 of the original cell number. 
8.3.2 Results  
Spotting assays of Ire1 mutants show that D836 allows for better ER stress tolerance in 
phospho-mutants when compared to D836A-phospho-mutants. Fig. 13 shows that under 
DTT induced ER stress, the D836A mutant shows the same level of growth across the 
increasing concentrations of DTT as seen in the WT. Reviewing the phospho-acceptor 
mutants, S840A-S841A shows the next highest levels of tolerance, achieving growth at 4 
mM of DTT in cells spotted with a dilution factor of 10-2. There are also very low levels of 
growth of cells with a dilution factor of 10-3. The Q-A was the next most tolerant of ER 
stress, again showing growth of cells at 4 mM DTT although not as strong growth as that 
seen in S840A-S841A, with cells growing only to the spot where the dilution factor was 
10-1. Finally, the P-A mutant showed the lowest tolerance of ER stress with growth at 3 
mM and very limited growth at 4 mM in the undiluted cell spot (much lower growth than 
S840A-S841A and Q-A). Reviewing the addition of the D836A mutation to the phospho-
acceptor mutants, D836A-S840A-S841A and D836A-Q-A both show around the same 
level of reduction in stress tolerance with growth stopping at around 2 mM of DTT, 
D836A-Q-A tolerating ER stress perhaps slightly better at this concentration (up to a 
dilution factor of 10-3). The D836A-P-A mutant survives marginally worse with growth 
again until 2 mM DTT, but in this case, only at the undiluted cell spot with very marginal 
growth beyond that.  
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Fig. 13 Spotting assays of PWY260+YCplac33-IRE1-HA cells on plates with 
increasing DTT concentrations. The results show that the inclusion of the D836A 
mutation to the a-loop phospho-mutants decreases survivability of ER stress in 
cells at lower concentrations of DTT. These assays were repeated three times with 
reproducible results.  
 
The same cell cultures of WT and the negative empty vector were spotted in Fig. 13. It can 
be seen that in the 2 mM plates, the empty vector shows growth on the bottom row, and no 
growth on the plate on the top row of the same concentration. As shown in the b-
galactosidase reporter assay data, the D836A-inclusive-phospho-mutants show levels of 
UPR activation seen in the empty vector (Fig. 11), as well as the empty vector itself 
showing no reporter activity. These data would suggest that at the same concentration used 
in the b-galactosidase, there would be an inability to tolerate ER stress as the UPR would 
not be activated. So how is there some growth of the empty vector with 2 mM of DTT. 
This may be a result of DTT exposure in different culturing methods. In liquid culture the 
DTT exposure, and therefore ER stress induction, is uniform. This is due to the constant 
agitation of the culture during incubation ensuring all cells are equally exposed to DTT. 
This may not be the case in spotting assays. A concentration gradient may develop over 
time on the plates used in the spotting assay as a result of metabolism or oxidation of the 
DTT. This could result in some cells being exposed to differing levels concentrations of 
DTT than others. 
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The PWY260 cells were also spotted onto plates containing Tn (Fig. 14), in this case 
results were different. Cells showed little to no growth with the introduction of Tn induced 
ER stress. The D836A mutant however showed increased tolerance of ER stress when 
compared to the WT, with colonies visible up to Tn concentrations of 1.0 µg ml-1. No other 
mutants showed growth, even at the lowest Tn concentration of 0.2 µg ml-1. 
 
 
 
Fig. 14 Spotting assays of PWY260+YCplac33-IRE1-HA cells on plates increasing 
in Tn concentration. The results show the inclusion of all mutations within the a-
loop decreases survivability of cells to the extent that growth is not recorded, 
exceptions being in WT and D836A at lower Tn concentrations. Interestingly the 
D836A mutant showed increased ER stress tolerance than that observed in the 
WT with stronger growth of cells at a dilution factor of 10-1 at a Tn concentration of 
0.2 µg ml-1. This phenotype was seen on all three repeats of these spotting 
assays.  
 
In addition to the Q-A mutant, constituent mutants of Q-A (S840A, S841A, T844A and 
S850A) were spotted on plates of increasing DTT and Tn (Fig 15). These mutations were 
also on the YCplac33 plasmid, transformed into the Y01907 strain. Phosphorylation of the 
a-loop is documented, often by reviewing complex double, triple or even more extensive 
mutants. Using a single residue mutation approach, it is possible to characterise the level of 
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participation of individual phosphorylation sites within the a-loop in relation to ER stress 
tolerance.  
In the case of DTT stress (Fig. 15 A), the S840A mutant possesses the highest tolerance of 
ER stress of the mutants when compared to the WT, achieving growth at 4 mM of DTT 
(growth achieved at the 10-2 dilution factor spot). The S841A and T844A mutants seem to 
suffer in stress tolerance to comparable levels to one another when compared to the WT, 
both achieving growth to 4 mM DTT (10-1 dilution factor spot). The S850A mutant, 
however, seems to show an increased tolerance to DTT-induced ER stress when compared 
to the WT showing growth up to the spot of cells diluted to a factor of 10-4. The pattern of 
these findings was replicated with Tn-induced ER stress (Fig.15 B).  
 
 
Fig. 15 Spotting assays of Y01907+YCplac33-IRE1-HA cells possessing the 
single point constituent mutants of Q-A within the a-loop on plates increasing in 
DTT (A) and Tn (B) concentration. Results show that in the case of both DTT and 
Tn, the mutation at phospho-acceptor sites reduces survivability with the exception 
of S850A, which appears to have improved survivability when compared to the 
WT. This phenotype was seen across the two repeats carried out.  
 
  
A 
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8.3.3 D836A mutation results in the reduction of ER stress tolerance in phospho-mutants  
Data presented suggests that the mutation of multiple phosphorylation residues has a 
cumulative effect on ER stress tolerance. The more extensive P-A mutant show the largest 
reduction in survival of ER stress whereas the S840A-S841A mutant showed the smallest 
reduction (Fig. 13). The D836 residue in all phospho-mutants further reduced the 
survivability of ER stress, to levels seen in the empty vector negative.   
An interesting result was the improvement of ER stress survival of the S850A mutant 
when compared to the WT (Fig. 15). With the UPR promoting tolerance to ER stress 
(Jäger et al., 2012; Lin et al., 2007), the data from spotting assay experiments suggest that 
the S850 residue of the a-loop may provide a level of control to ER stress signalling when 
the other a-loop phospho-acceptor sites are phosphorylated. With the S850A mutation this 
control may be removed, allowing for unrestricted UPR activation resulting in improved 
survivability of ER stress compared to the WT.  
The D836A mutant increasing survivability under Tn stress conditions in PWY260 is more 
obscure (Fig. 14). As seen in the b-galactosidase assay results, D836A mutants did not 
elicit higher levels of reporter activity suggesting that UPR activation was not elevated. 
This raises the question as to why the D836A mutant would achieve growth at higher Tn 
concentrations than achieved by the WT? It may be a possibility that the Tn may have a 
differing effect on Ire1 in PWY260 as this phenotype was not observed in cells grown 
under ER stress induced by DTT. However, in the literature it has been shown that WT S. 
cerevisiae cells should be able to tolerate concentrations of Tn used in this work (Lee et 
al., 2008; Schröder et al., 2003). This could mean that either the PWY260 cells are much 
more sensitive to Tn stress than Y01907. Alternatively, there may have been an error 
regarding the concentrations of Tn used. To establish either of these theories, the spotting 
assay would require repetition on plates with lower concentrations of Tn, using both 
PWY260 and Y01907 strains.  
The role D836 plays in the ER stress response seems to impact on the ability for cells to 
tolerate ER stress. With DTT stress, the S840A-S841A and Q-A mutants showed reduced 
survivability when compared to the WT. The more extensive P-A mutant appeared to be 
more susceptible to ER stress (Fig. 13). This reduction in survival of ER stress was not 
absolute. With the inclusion of D836A to the phospho-acceptor mutants, all cells show a 
further reduction in ER stress tolerance induced by DTT, to that seen in the empty vector. 
The UPR in yeast is involved in promotion of cell tolerance, and survival of ER stress 
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(Chen and Brandizzi, 2013; Jäger et al., 2012; Lin et al., 2007) the results presented here 
indicate that the failure to alleviate ER stress results in reduced growth and maybe the 
cause of decreased survivability of ER stress. More extensive mutations to the a-loop 
phosphorylation sites of Ire1 appear to reduce the concentration of ER stressor required for 
reduced growth indicative of reduced ER stress tolerance. These data link the in vitro 
reporter assay activity results and the effect on ER stress tolerance in vivo. It should be 
taken into consideration that the single mutant constituents of Q-A utilised Y01907 strain 
of S. cerevisiae as opposed to PWY260 in the multi-point mutants. Although the plasmids 
are identical and show similar growth and expression data. For clarification, these mutants 
would need repeating in PWY260. 
8.4 Characterising the clustering of Ire1 in a-loop mutants under ER stress 
8.4.1 Rationale 
When Ire1 detects unfolded proteins in the ER lumen, it forms dimers and possibly 
promotes oligomerisation. Although as mentioned previously, the exact mechanics of this 
process are debated (Credle et al., 2005; Kimata et al., 2007; Mathuranyanon et al., 2015; 
Pincus et al., 2010; Shamu and Walter, 1996; Zhou et al., 2006), it is agreed that the Ire1 
molecules themselves “cluster” in the event of ER stress. With the use of the mutants in 
this work it is important to show that this clustering is being achieved in all mutants. This 
is because the clustering of Ire1 is indicative of an initiation of the ER stress response 
(Aragón et al., 2009; Kimata et al., 2007) and would ensure that the results seen in the b-
galactosidase reporter assays and spotting assays were not simply a result of defects in Ire1 
clustering resulting in a reduction in UPR activation. To investigate the Ire1 protein 
clustering following activation through unfolded protein accumulation, MSY14-02 strain 
S. cerevisiae cells were transformed with two plasmids, pJK59 and pEvA97. pJK59 was 
already transformed into the MSY14-02 strain and through the inclusion of the GFP-tagged 
Sec63 allowed for visualisation of the membrane of the perinuclear and cortical ER and the 
determination of localisation of Ire along the ER membrane when using a fluorescently 
tagged Ire1, hence the use of this strain. Furthermore, in previous studies completed by the 
Schröder laboratory at Durham University, the MSY14-02 strain was found to express the 
pEvA97 plasmid with the best results. The pEvA97 plasmid, contained the mCherry-
tagged IRE1 (details in Fig.6) which allowed for the visualisation of Ire1 localisation. With 
the use of the Zeiss LSM 880 with Airyscan microscope, images were captured over a 1 h 
time course showing how cells responded to ER stress induced by 2 mM of DTT. Should 
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the activation of Ire1 not be initiated by ER stress then then Ire1 would not be expected to 
form foci (Aragón et al., 2009; Kimata et al., 2007). If Ire1 is behaving as would be 
expected in the WT, then after around 15 min, clustering of the mCherry signal should be 
apparent.  
8.4.2 Results 
To ensure cells expressing both Ire1 and Sec63 could be visualised, a 2-channel approach 
was used. Additionally, cells were only imaged if signals from both Ire1-mCherry and 
Sec63-GFP were detected. In cells under no ER stress, the Ire1 signal should be arranged 
in such a way as that there are no specific foci sites as the UPR is not being activated 
(Kimata et al., 2007). The Ire1 should be evenly spread along the cortical and perinuclear 
ER membrane (Fig. 16). Sec63 is an ER membrane protein and a commonly used ER 
marker in the field, (Prinz et al., 2000; Schuck et al., 2009; Voeltz et al., 2006) and should 
remain unchanged by the introduction of ER stress from DTT, this will serve as a control 
ensuring that a phenotype has not arisen in the arrangement of the ER from the 
introduction of the a-loop mutations as well as indicating that the Ire1-mCherry is local to 
the ER membrane. 
 
Fig. 16 MSY14-02 expressing Ire1 tagged with the mCherry fluorophore. The 
localisation of Ire1 protein to the perinuclear ER (A) and the cortical ER (B) under 
no ER stress. Scale bar 5 µm. 
 
A 
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Under ER stress conditions Ire1 begins to form clusters, this can be seen from the 15 min 
time point in Figs. 17 – 24 below. This is as the Ire1 proteins cluster together along the ER 
and produce a stronger mCherry signal. To show the lack of any phenotype, all mutants, at 
all time points, should exhibit the same characteristics as those seen in the WT. All images 
presented below are representative of the mutants. Around 30 - 50 images were taken per 
mutant on the microscope, with each image containing an average of 2 – 5 cells. Ideally 
one cell at a time would be viewed over the time course but this is not possible because of 
photo-bleaching with prolonged laser exposure. However, the approach implemented here 
should accurately represent clustering of Ire1 in the mutants induced by ER stress using 2 
mM of DTT. 
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Fig. 17 Time course of the MSY14-02+pJK59 (WT) mutant. The 0 min time point 
shows the localisation of the Ire1 protein along the membrane of the cortical and 
the perinuclear ER. As DTT exposure time increased the Ire1 signal begins to 
cluster into foci sites. This is seen from the 15 min time point, some signal evenly 
spread along the cortical ER remains however this is reduced as the treatment 
time progresses. Upon 60 min of DTT exposure the Ire1 signal appears to be 
exclusively confined to the foci sites. Scale bar 5 µm.   
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Fig. 18 MSY14-02+pJK59+pEvA97-D836A time course. The D836A mutant elicits 
no phenotype regarding the clustering of Ire1 into foci sites. The Ire1 foci sites 
form again after 15 min. Upon 60 min of DTT exposure the Ire1 signal appears to 
be exclusively confined to the foci sites. Scale bar 5 µm.  
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Fig. 19 MSY14-02+pJK59+pEvA97-S840A-S841A time course. S840A-S841A 
shows the localisation of Ire1 signal to foci sites from the 15 min DTT treatment 
time point, as seen in the other mutants and the WT. Upon 60 min of DTT 
exposure the Ire1 signal appears to be exclusively confined to the foci sites. Scale 
bar 5 µm 
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Fig. 20 MSY14-02+pJK59+pEvA97-D836A-S840A-S841A time course. D836A-
S840A-S841A mutant arranges its Ire1 as seen in the other mutants and the WT. 
The Ire1 foci sites form, as before, following 15 min of DTT treatment. Upon 60 
min of DTT exposure the Ire1 signal appears to be exclusively confined to the foci 
sites. The inclusion of the D836A mutation to the S840A-S841A mutant resulted in 
the same DTT stress foci site arrangement as seen in other mutants. Scale bar 5 
µm.  
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Fig. 21 MSY14-02+pJK59+pEvA97-Q-A time course. The Q-A mutant, as with the 
other mutants shows no phenotype regarding the clustering of Ire1 into foci sites. 
The Ire1 foci sites form, as before, after 15 min of DTT treatment. Upon 60 min of 
DTT exposure the Ire1 signal appears to be exclusively confined to the foci sites. 
Scale bar 5 µm. 
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Fig. 22 MSY14-02+pJK59+pEvA97-D836A-Q-A time course. As with all previous 
mutants, the D836A-Q-A mutant results in no clustering phenotype. The Ire1 foci 
sites form, as before, after 15 min of DTT treatment. Upon 60 min of DTT 
exposure the Ire1 signal appears to be exclusively confined to the foci sites. These 
images show that the addition of the D836A mutation to the Q-A mutant resulted in 
the same DTT stress foci site arrangement as seen in the WT and mutants. Scale 
bar 5 µm. 
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Fig. 23 MSY14-02+pJK59+pEvA97-P-A time course. The P-A mutant elicits no 
clustering phenotype. The Ire1 foci sites form after 15 min and continue to show 
this arrangement of foci site specific signal over the 60 min treatment. Scale bar 5 
µm.   
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Fig. 24 MSY14-02+pJK59+pEvA97-D836A-P-A time course. The addition of the 
D836A mutation to the P-A mutant results in no phenotype regarding the clustering 
of Ire1 into foci sites. The Ire1 foci sites form after 15 min of DTT treatment. Upon 
60 min of DTT exposure the Ire1 signal appears to be exclusively confined to the 
foci sites. It was important that the addition of the D836A mutation along with the 
a-loop phospho-site mutations did not produce phenotype which would explain the 
further attenuation of UPR shown by phospho-mutants containing a D836A. These 
images show that this is not the case and therefore any reduction in UPR is not 
resulting from a non-clustering phenotype. Scale bar 5 µm.   
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8.4.3 Mutants produce no clustering phenotype under ER stress  
The images gathered from fluorescence microscopy highlight the clustering of the Ire1 
protein along the ER membrane. The visualisation of the foci sites however does not 
confirm RNase activity, simply that the Ire1 has formed foci sites in response to unfolded 
protein accumulation in the ER lumen. To ensure that the apparent reduction of ER stress 
response in the phospho-mutants is not a result of an Ire1 clustering phenotype it would be 
expected that all mutants would behave as the WT. Figs. 17 – 24 show that the mutants 
follow the same clustering as the WT, whereby at the 15 min time point, the clustering is 
apparent and after 60 min of DTT exposure the Ire1 signal appears to be exclusively 
confined to the foci sites along the ER membrane. This shows that Ire1 still clusters in 
response to ER stress even with a D836A mutation or phosphorylation site mutations, or a 
combination of both, showing the mutations do not result in a lack of Ire1 clustering.  
The role phosphorylation may be playing in the formation of clusters of Ire1 may not be 
indispensable. As discussed in section 6.5, phosphorylation of the a-loop was thought to 
facilitate nucleotide binding by activating the kinase domain (Lee et al., 2008) resulting in 
a dimer configuration and RNase activation. Alternatively, due to conformational changes 
following phosphorylation of the a-loop, phosphorylation was thought to promote 
autophosphorylation in trans promoting the formation of oligomers and that this 
oligomerisation was critical to RNase activity (Korennykh et al., 2009). The data presented 
in Figs. 17 – 24 show that there is no Ire1 clustering phenotype produced in WT cells or in 
phospho-acceptor site mutants, both including and excluding the D836A mutation. 
However, the observation of foci sites of Ire1 only illustrates clustering and does not 
confirm the formation of dimers or oligomers. To investigate the formation and structure 
of oligomers then the crystal structure of Ire1 exposed to ER stress would have to solved. 
The only conclusion that can be drawn from the visualisation of clusters of Ire1 is that, the 
reduction in ER stress signalling by Ire1 is not a result of a lack of clustering negatively 
impacting on the UPR activation (Aragón et al., 2009; Kimata et al., 2007). 
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9.0 Discussion 
The data gathered above indicate that the D836 residue plays a role in the regulation of 
RNase activity, suggesting that phosphorylation alone is not the exclusive activator of 
RNase activity or that phosphorylation does not act alone in RNase activation. b-
galactosidase reporter assay data shows that the phospho-acceptor mutants (S840A-S841A, 
Q-A and P-A) show an attenuation of the activation of UPR. Furthermore, this attenuation 
is increased relative to an increase in the number of phospho-acceptor-site mutations. The 
inclusion of the D836A to mutation to these mutants reduced UPR activation to levels seen 
in the empty vector negative control.  
Linking UPR to cell survivability of ER stress, the results from spotting assays mimic 
those seen in b-galactosidase reporter assays, whereby S840A-S841A, Q-A and P-A 
mutants have a reduced survivability of ER stress conditions, again with P-A exhibiting the 
largest reduction in ER stress tolerance compared to the WT. Once again the inclusion of 
the D836A mutation to these mutants decreases tolerance of ER stress further, to levels 
seen in the empty vector control. Finally, the fluorescence microscopy highlights no Ire1 
clustering phonotype or the ER arrangement in general when compared to the WT. This 
confirmed that all previous observations of the impact of mutants were not a result of 
reduced or eliminated clustering of Ire1 in vivo under ER stress.  
9.1 Inclusion of D836A eliminates residual UPR activation in a-loop phospho-mutants 
Phosphorylation within the a-loop was thought to activate the kinase domain by causing 
conformational changes to the a-loop and opening the nucleotide pocket to allow the 
binding of ATP, the hydrolysis of which resulted in the formation of a dimer which 
promotes RNase activity, dependent on the occupation of the NBP (Lee et al., 2008; Papa 
et al., 2003). The alternative model was that ADP binding would then induce Ire1 the 
dimerisation promoting kinase activity and facilitate the formation of oligomers. This 
oligomerisation compatible conformation was “locked in” by phosphorylation of the a-
loop promoting the formation of an oligomer and activating the RNase domain 
(Korennykh et al., 2009; Shamu and Walter, 1996; Welihinda and Kaufman, 1996). The 
activation of the RNase domain initiates HAC1 mRNA splicing and ultimately leads to the 
expression of UPR associated genes (Tanaka et al., 2015). Two observations in previous 
work go against parts of these models. Firstly, the D828A mutant described as kinase dead 
due to its lack of Mg2+ coordination (Chawla et al., 2011) and D797A-K799A mutant 
which no longer possess a catalytic aspartate (Rubio et al., 2011) still show RNase activity. 
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This suggests that the kinase activity is not indispensable for RNase activity. Secondly, in 
mutants that still possess kinase activity but lack some, or all, of their phospho-acceptor 
sites within the a-loop (S840A-S841A, Q-A and P-A) there was a retention of levels of 
RNase activity (Schröder et al., unpublished work) (Fig. 5). This suggests that 
phosphorylation also is not indispensable in RNase activation. All of these mutants possess 
an aspartic acid at residue 836 in the a-loop sequence. In the RD kinase model, 
phosphorylation within the a-loop promotes a-loop interaction with the RD pocket to 
promote nucleotide binding (Johnson et al., 1996; Knighton et al., 1991; Nolen et al., 
2004). In the absence of phosphorylation, RD kinases have been shown to utilise a 
glutamate residue to mimic this interaction due to the negative charge of this amino acid 
(Johnson et al., 1996). It was proposed in this work that the phosphorylation could be 
bypassed by the mimicry of the active conformation of the a-loop by the negative charge of 
the D836 residue.  To investigate the role of D836 in Ire1 the work presented here used a 
range of mutants with reduced or eliminated phospho-acceptor capability within the a-loop 
that had been used in previous studies by the Schröder laboratory, however, this time also 
used these same mutants with the addition of D836A (D836A, S840A-S841A, D836A-
S840A-S841A, Q-A, D836A-Q-A, P-A and D836A-P-A) (Fig. 2). The findings show that 
in non-D836A mutants residual Ire1 activity was detected were seen again in this work, 
this time using an UPRE-associated b-galactosidase reporter assay (Figs. 11 and 12). The 
inclusion of D836A to the phosphorylation site mutants resulted in complete elimination of 
reporter activity (Fig. 12 B, C and D). The single mutant D836A, however, shows no 
reduction in reporter activity (Fig. 12 A). These data suggest that D836 is facilitating a 
basal level of Ire1 activity in the event of loss of phosphorylation. This compensatory 
effect seems to reduce with the more extensive mutants (Fig. 11 A). In the S840A-S841A 
mutant, D836 appears to be able to allow retention of most of the Ire1 activity. Q-A suffers 
higher attenuation of it’s Ire1 activity than S840A-S841A, with P-A being the most 
reduced. All of these mutants possess a D836 residue, however S840A-S841A also retains 
the native S837, T844 and S850 sites, suspected phosphorylation sites (Lee et al., 2008; 
Shamu and Walter, 1996). The Q-A mutant has its T844 and S850 residues changed to 
alanine (S840A-S841A-T844A-S850A) but still possesses S837. The P-A mutant also has 
its S837 mutated to alanine (S837A-S840A-S841A-T844A-S850A). The increase in the 
number of a-loop phosphorylation sites correlates with a decrease in the compensatory 
effect of D836, suggesting that this effect is optimised by phosphorylation on the S837, 
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T844 and S850 residues, with less phosphorylation resulting in a reduced ability of D836 
to activate RNase activity (Fig 11 A). The introduction of the S837A mutation in the P-A 
mutant compared to the Q-A mutant reduces the effect of D836, showing experimental 
evidence that S837 is involved in Ire1 activity, probably through phosphorylation. Direct 
observation of phosphorylation on this residue would be required to solidify this theory.  
The theory that the compensatory effect of D836 is dependent on phosphorylation on the 
S837, T844 and S850 residues is validated by the result that in D836A-S840A-S841A 
mutants, reporter assay activity is at levels seen in the empty vector control. This means 
that despite the phosphorylation sites of S837, T844 and S850 being available, these are 
not sufficient to result in Ire1 RNase activity without D836. If D836 is providing a form of 
rescue from a defect in a-loop phosphorylation there are several questions to be reviewed. 
How does phosphorylation of the a-loop lead to Ire1 RNase activation and is this 
dispensable? How does D836 achieve its compensatory effect? Finally, what are the roles 
of the phospho-acceptor residues within the a-loop?  
In response to the question of how phosphorylation activates Ire1 RNase activity and the 
dispensability of this system, it has been shown that phosphorylation of the a-loop of Ire1 
is required for efficient HAC1 mRNA splicing (Prischi et al., 2014) and that Ire1 molecules 
rely on trans-autophosphorylation (Korennykh et al., 2009; Lee et al., 2008; Pike et al., 
2008; Pirruccello et al., 2006; Shamu and Walter, 1996) which promotes a conformation of 
the cytosolic domain compatible with RNase activation (the exact confirmation is debated 
see section 6.5 and above). It should be noted that the work completed by Prischi et al., 
(2014) utilised human Ire1a, which may behave differently to the Ire1 of S. cerevisiae. 
Based on the models above where phosphorylation ultimately facilitates the RNase 
compatible conformation of the RNase domain, in the event where all phosphorylation 
sites are mutated, such as in P-A, induction of the b-galactosidase reporter seen in Fig. 12 
D must be achieved through a mechanism independent of phosphorylation. This 
conclusion can be drawn because if a mechanism relies on phosphorylation of the a-loop to 
phosphorylate its neighbours in trans then loss of phosphorylation at these sites must 
prevent this event. As shown however, Ire1 with no phospho-acceptor sites within the a-
loop still shows reporter activity (Fig. 11 and Fig. 12 D) and HAC1 splicing (Fig. 5) hence 
a-loop phosphorylation appears to be dispensable in Ire1 activity, however, RNase activity 
will be reduced.  
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The answer to the second question of if phosphorylation is dispensable then how does Ire1 
regulate its RNase domain may lie in the RD kinase family. Ire1 possesses an “RD pocket” 
comprised of a conserved arginine at residue 796 (R796) followed by a conserved catalytic 
aspartic acid (D797) (Johnson et al., 1996; Nolen et al., 2004). The evidence that efficient 
HAC1 mRNA splicing requires phosphorylation of the a-loop of Ire1a (Prischi et al., 
2014) suggests that Ire1 is a phosphorylation-dependent RD kinase. However, as 
previously mentioned, Ire1a may not behave the same as yeast Ire1, but other studies have 
shown that UPR is at its most efficient with phosphorylation on primary residues within 
the a-loop (Shamu and Walter, 1996). It has been described that in RD kinases the 
phospho-acceptor residues within the a-loop are involved in an electrostatic interaction 
between with the RD pocket which is critical for driving the conformation change required 
for kinase activity (Nolen et al., 2004). Furthermore, Nolen et al., (2004) suggest that the 
arginine (R797 in S. cerevisiae) is not the source of a direct signal of activation to the 
kinase catalytic loop. It is suggested that the interaction between the a-loop and the RD 
pocket facilitates a conformational change to the N and C-terminal anchors of the a-loop. 
This change allows for nucleotide binding, thought to be important in RNase activation 
(Mannan et al., 2013; Papa et al., 2003). The role of phosphorylation may be providing a 
level of stability in the resulting conformational changes of the a-loop allowing for an open 
and extended conformation permitting this nucleotide binding (Huse and Kuriyan, 2002).  
The theory that phosphorylation provides stability may be supported by data presented 
here. In the S840A-S841A mutant there was the highest recorded residual reporter assay 
activity, however, the D836A-S840A-S841A mutant showed no activity despite it 
possessing three functioning phosphorylation sites (Fig. 12 B). As already discussed this 
would suggest that D836 is reliant on the phosphorylation of S837, T844 or S850. The fact 
that the maximum effect of D836 on reporter activity is seen in mutants still capable of 
phosphorylation within the a-loop provides evidence that phosphorylation does indeed 
provide stability to the a-loop conformational changes suggested (Huse and Kuriyan, 2002) 
allowing for efficient nucleotide binding and RNase activation. To expand, when less 
phosphorylation sites are available (Q-A and P-A) the compensatory effect of D836 is 
reduced (Fig. 11 A), possibly because D836-induced a-loop conformational changes lack 
the stability provided by phosphorylation. The S841 site is positioned within the a-loop in 
such a way that it is thought to interact with the RD pocket and provide stability to the 
oligomer (Korennykh et al., 2009). This would suggest that S841 is a primary 
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phosphorylation site, as it is common for the primary phosphorylation site of 
phosphorylation-dependent RD kinases to interact with the RD pocket (Nolen et al., 2004). 
As it was suggested that S840 and S841 may work in tandem (Shamu and Walter, 1996), 
this may explain why in the mutants Q-A and P-A there is the largest attenuation of ER 
stress signal transduction.  
If the favourable mechanism of phosphorylation of Ire1 in the a-loop relies on primary 
phosphorylation sites within the a-loop interacting with the RD pocket, D836 may mimic 
this conformational change to facilitate nucleotide binding. This conformational mimicry 
may be a result of the position of D836 within the a-loop and its negative charge. The 
stabilisation provided by phosphorylation of S837 in Q-A provides a more stable 
conformer allowing for more efficient nucleotide binding, hence the improved 
compensatory effect of D836. The S840A-S841A mutant with its highest level of residual 
ER stress response has the benefit of additional conformation stability provided by 
phosphorylation of one, two or all three of the S837, T844 or S850 residues. The idea of 
primary sites of phosphorylation also explains the loss of residual activity of D836A-
S840A-S841A. There would be little evolutionary advantage to have a system whereby 
compensation for loss of phosphorylation is maximised by phosphorylation at the primary 
sites (especially if these sites are working in tandem as suggested (Shamu and Walter, 
1996)). Should the primary sites lose phospho-acceptor capability, a compensatory system 
based on this method would be redundant. The use of secondary phosphorylation sites such 
as S837, T844 and S850 would allow for an alternative pathway with the flexibility of 
three independent phosphorylation sites to provide conformation stability. 
Protein kinases are known to have a high degree of plasticity allowing for the adoption of 
different conformations to promote activity (Huse and Kuriyan, 2002). The D836 residue 
appears to allow for at least partial bypassing of phosphorylation of the a-loop of Ire1 in S. 
cerevisiae. The method by which this is achieved may be through mimicry or assistance in 
the facilitation of conformational changes promoting RNase activation and hence 
endoribonuclease activity resulting in activation of the UPR.  
The final question of how the other phosphorylation residues within the a-loop are linked 
to RNase activity and UPR activation may be answered in part by the theory outlined 
above regarding the role of D836. It has already been documented that the S840, S841 and 
T844 residues are involved in the formation and stabilisation of the crucial IF3c through 
the formation of intramolecular salt bridges. In their phosphorylated state, the position of 
the phosphates of these three residues are arranged in such away the promote the 
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oligomerisation compatible conformation thought to be required for RNase activity 
(Korennykh et al., 2009). S837 and S850 appear to be involved in ER stress signal 
transduction (Fig. 11 and Fig. 15). There are two anchor points for the activation segment 
of Ire1, the N-terminal anchor and C-terminal anchor (Nolen et al., 2004). In many kinases 
the conformation of an inactive a-loop disrupts the N-terminal anchor, distorting the Mg2+ 
binding loop, (Nolen et al., 2004; Xie et al., 1998; Yang et al., 2002). This distortion may 
contribute to reduced activity by preventing the correct positioning of ATP (Nolen et al., 
2004). This also may explain the contradiction in the models whereby a low level of kinase 
activity seems to be required to initiate the trans-autophosphorylation of Ire1 in the outset 
(see section 6.5). The Mg2+ binding loop and the b10 sections (Fig 2.) form the N-terminal 
anchor. The C-terminal anchor begins near the middle of the P + 1 loop and extends 
towards the APE conserved region. This anchor is critical in the interaction between the 
substrate and the kinase (Madhusudan et al., 1994). The S837 is located nine amino acids 
downstream from the DFG motif, which is at the N-terminal end of the N-terminal anchor. 
S850 is located nine amino acids upstream from the APE conserved motif at the C-
terminal end of the C-terminal anchor. As the DFG and APE motifs are highly conserved 
(Fig. 2) (Mannan et al., 2013) and phosphorylation is believed to stabilise a-loop 
conformations, it may be the case that the S837 and S850 residues are placed in such a way 
to provide stability through interaction with activation segment anchors.  
9.2 Inclusion of D836A to phospho-acceptor site mutants reduces cell survivability in 
ER stress conditions 
It is evolutionarily encoded in cells to promote cell death when under excessive and stress 
from protein accumulation from which the cell is unable to recover. The UPR is a 
mechanism by which the cell processes accumulated proteins in the ER, should this system 
be unable to achieve this, then the cells suffer a reduction in survivability of ER stress 
(Chen and Brandizzi, 2013; Hetz, 2012; Jäger et al., 2012; Lin et al., 2007; Merksamer and 
Papa, 2010; Shore et al., 2011). PWY260 cells have shown a reduction in survivability 
when transformed with a-loop mutations preventing phosphorylation. Furthermore, the 
addition of the D836A mutation to these mutants further reduced cell tolerance to ER 
stress (Fig. 13).  
Fig. 13 suggests that the idea that D836 allows for the role of phosphorylation to be 
partially bypassed is occurring in vivo. In phospho-mutants cell survival is reduced but not 
as detrimentally to the levels seen in the empty vector control. The addition of the D836A 
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mutation to phospho-mutants decreases survivability further, to the levels seen in the 
empty vector (-) control (Fig. 13). This suggests that D836 plays a role in facilitating 
activation of the UPR and hence promoting cell survival in phospho-mutants. ER stress 
induced by DTT effects D836A inclusive phospho-mutants at lower concentrations of DTT 
than cells with the native D836. Three other interesting questions were raised by the 
spotting assay results, however. Firstly, when ER stress was induced by tunicamycin the 
D836A mutant appeared to have improved stress tolerance. Secondly, the S850A mutation 
improved stress tolerance in both DTT and Tn induced ER stress when compared to the 
WT in Y01907 cells. Finally, that the single point mutations of the Q-A mutant (S840A, 
S841A, T844A and S850A), were able to tolerate ER stress much more readily than their 
multipoint mutant counterparts. 
Addressing the first question, of increased survival of ER stress in the D836A mutant when 
compared to WT. This result was not expected and has not previously been reported in the 
literature. As discussed in section 8.3.3, WT S. cerevisiae cells should be able to tolerate 
concentrations of Tn used in this work (Lee et al., 2008; Schröder et al., 2003). This could 
mean that either the PWY260 cells are much more sensitive to Tn stress than Y01907 or an 
error in Tn concentrations used. Repetition of the D836A mutant alongside the WT on 
lower concentrations of plates using both PWY260 and Y01907 strains could help in 
understanding a definitive reason for this phenotype. The data collected in this work shows 
no increase in Ire1 expression in D836A mutants, no increase in b-galactosidase reporter 
activity and no Ire1 clustering phenotype when reviewed in fluorescence microscopy. 
HAC1 mRNA splicing assays would allow for the investigation into the RNase activity 
levels of the D836A mutant whilst under Tn induced ER stress would also shed light on 
any link between RNase activity and increased ER stress tolerance in D836A mutants. This 
experiment should be carried out using DTT and Tn as ER stressors to understand the 
apparent Tn-specific phenotype.  
Considering the second question of why does the S850A mutant in Y01907 show a 
phenotype of improved ER stress tolerance induced using DTT and Tn it must be 
considered the role S850 could play in the activation loop of Ire1. The idea that Ire1 
function is not reduced by the mutation of S850 has been observed previously (Lee et al., 
2008), where a S850A Ire1 mutant behaved as in the WT in terms of ER stress tolerance 
(assessed by spotting assays grown on Tn). However, the phenotype characterised by 
improved growth under ER stress has not been observed. Residues providing regulator 
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function is not unprecedented in Ire1, D828 in the kinase domain has been suggested to be 
important in the deactivation of Ire1 RNase activity (Chawla et al., 2011), perhaps S850 
plays a similar regulatory role? As discussed in section 9.2 above, the S850 residue is 
located just outside the a-loop in the P+1 loop (Fig. 2). This loop was originally identified 
due to its involvement in contacting the P+1 residue structure of the kinase PKA with 
bound peptide inhibitor, and is found at a critical interaction between substrate and the 
kinase (Madhusudan et al., 1994; Nolen et al., 2004). This activity of the P+1 loop and 
position of the S850 residue within the loop might hint at the result of increased tolerance 
of ER stress. If the S850 residue is mutated, then the interaction between the P+1 loop and 
the kinase may be prevented. This may leave the Ire1 a-loop “active” due to the proximity 
of the S850 residue to the C-terminal anchor causing unregulated nucleotide binding 
resulting in RNase activity, as the anchors of the a-loop are important for conformation 
(Nolen et al., 2004). The subsequent increased UPR activation could result in increased ER 
stress survival compared to the WT. 
Finally, is the observation that the constituent single point mutations of Q-A (S840A, 
S841A, T844A and S850A), seem to retain a higher level of ER stress tolerance than that 
exhibited by the combined Q-A mutant. This may highlight the role phosphorylation is 
playing in the activation of the Ire1 RNase activity, not involving the D836 residue. 
Comparing the multi-point mutant Q-A to its constituent single point mutants it can be 
seen that the Q-A mutant suffers from a lack of ER stress tolerance at lower concentrations 
of DTT than in the single point mutants (Figs. 13 and 15). Data shows that the S841A and 
T844A mutants show the largest sensitivity to DTT stress at 4 mM, similar to the levels of 
the Q-A mutant. It was noted that these residues were of particular importance in 
phosphorylation mediated Ire1 activation previously (Shamu and Walter, 1996). The 
S840A single mutant tolerates stress better than the Q-A mutant at 4 mM of DTT and the 
S850A has improved tolerance even compared to the WT (as discussed). The observation 
that the inclusion of multiple phosphorylation site mutations results in reduce ER stress 
survival in the Q-A mutant supports the b-galactosidase reporter data that the more 
extensive mutations result in an accumulative effect on ER stress tolerance (Fig. 11), as the 
single point mutants all tolerate ER stress either at around the same level or better than in 
the Q-A mutant. As S841A is believed to be a primary phosphorylation site and critical to 
RNase activation and Ire1 activity (Korennykh et al., 2009; Shamu and Walter, 1996), it 
would be expected that any mutant (such as Q-A) would suffer in a lack of effective UPR 
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activation by the presence of a S841A mutant. The S840 residue is believed to act in 
tandem with S841 (Shamu and Walter, 1996) compounding the reduction in ER stress 
signalling in Q-A and P-A mutants illustrating the effects of more extensive 
phosphorylation-site mutation. These spotting assays also indicate the role of S837 in UPR 
activation. The P-A mutant again shows reduced ER stress tolerance, exhibited by lack of 
growth at lower DTT concentrations, when compared to the Q-A mutant (Fig. 13). The 
only residue that the Q-A mutant possesses that the P-A does not is the S837 suggesting 
that it is indeed a functioning residue in the activation of Ire1. 
9.3 Mutations in the activation loop do not produce an Ire1 clustering arrangement 
phenotype  
As mentioned previously (section 6.2), there is much debate over the mechanics of how the 
lumenal domain of Ire1 detects unfolded protein accumulation. Regardless, once activated 
the process of lumenal domain dimerisation or oligomerisation allows for the formation of 
foci sites along the ER when unfolded protein accumulation stress is induced with DTT 
(Anshu et al., 2015). These foci suggest that Ire1 can still cluster when ER stress is induced 
despite the modifications made to its amino acid sequence. The lack of an Ire1 clustering 
phenotype in all mutants when compared to the wild type confirms that the lack of RNase 
activity and hence UPR activation is not a result of a reduced ability for Ire1 to form 
clusters. These data support the idea that clustering of Ire1 is believed to be a prerequisite 
of downstream signalling (Aragón et al., 2009; Kimata et al., 2007), however show that the 
clustering alone is not enough to activate Ire1. This is shown by D836A-containing 
phospho-mutants such as such as D836A-S840A-S841A, which still cluster under DTT-
induced ER stress, yet have no UPR activity (Fig. 5, Fig. 12 B and Fig.20). This suggests 
that the phosphorylation (or mimicry of phosphorylation by D836) is important to the 
activation of Ire1. In all mutants, the Ire1 forms clusters. In the case of the D836A-
phospho-mutnats, there is a complete attenuation of b-galactosidase reporter activity (Fig. 
11 B) and in spotting assays these same mutants suffer in terms of ER stress tolerance (Fig 
13). This suggests that the role of phosphorylation or D836 is to promote the active 
conformation requited from RNase activity after clustering (Korennykh et al., 2009; Lee et 
al., 2008; Nolen et al., 2004; Shamu and Walter, 1996), as without phosphorylation or the 
compensatory response of D836, Ire1 activation appears to stop at the stage of clustering. 
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10.0 Conclusions and Future Interests 
10.1 Summary of findings and conclusions 
This work has shown that the D836 residue of Ire1 appears to allow for a partial bypassing 
of phosphorylation. However, this maximising of the effect of D836-mediated bypassing is 
reliant on the phosphorylation sites of S837, T844 or S850 residues for the maximum 
retention of UPR activation by D836 in Ire1. This indicates that there may be a form of 
hierarchy in the phosphorylation sites in that, the S841, working in tandem with the S840 
act as primary phosphorylation sites. T844 as a secondary and the roles of S837 and S850 
perhaps being important in the conformation stability of the phosphorylated a-loop 
promoting efficient nucleotide binding. The D836 residue appears to have its maximum 
potential for retention of RNase activity in the presence of phosphorylation on S837, T844 
and S850. The stabilisation of the a-loop in a conformation permissive of kinase activity 
has been suggested to be facilitated by phosphorylation and the resulting kinase activity 
actives the RNase domain (Lee et al., 2008; Nolen et al., 2004). Alternatively, initial 
oligomerisation may promote kinase activity which allows for a-loop phosphorylation and 
the formation of higher-order oligomers which activates the RNase domain (Korennykh et 
al., 2009). In both cases the activation of Ire1 appears to involve phosphorylation of the a-
loop permitting a stable conformation resulting in RNase activation. Data presented in this 
thesis suggests that phosphorylation is dispensable due to the retention of Ire1 activity in 
mutants with no phospho-acceptor capability in the a-loop. This retention of Ire1 activity 
appears to be facilitated by D836. However, this retention is maximised by the 
phosphorylation of residues in the a-loop, namely S837, T844 and S850 shown in this 
work. This suggests a new model for the role of phosphorylation of Ire1 in its regulation of 
Ire1 RNase activity. Ire1 appears to not be dependent on total phosphorylation of it’s a-
loop, but possesses the ability to retain levels of RNase activity, utilising additional, non-
phosphorylation, sites within the a-loop, namely D836. In the event of partial loss of 
phosphorylation one of two events may occur. Should phosphorylation be lost from a 
primary site (S840 or S841) then the D836 residue would mimic the a-loop conformational 
changes normally associated with phosphorylation and this conformation would be 
stabilised by phosphorylation of the secondary phosphorylation residues S837, T844 and 
S850. Should complete phosphorylation capability of the a-loop be lost then D836 can still 
provide a limited level of ER stress signal response mimicking a-loop phosphorylation but 
without the secondary residues being phosphorylated this response would appear to be 
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limited. This model would explain the phosphorylation of residues in the a-loop observed 
my mass spectroscopy (Lee et al., 2008),  as well as the importance of the S841 residue 
working with S840 (Shamu and Walter, 1996). Additionally it is supported by the first 
experimental evidence of the role of S837 in ER stress signal transduction first theorised in 
the 90s (Shamu and Walter, 1996). The work presented here suggests that the 
conformation of the a-loop and kinase domain may be the driving factor in the regulation 
of RNase activity in Ire1, with phosphorylation playing, in part, a dispensable role. 
10.2 Future interests 
10.2.1 Characterising the role of individual phosphorylation sites within the a-loop  
More data on the how much each of the phosphorylation residues impacts upon Ire1 
activation would provide an improved understanding of the possible phosphorylation site 
hierarchy. The data presented here suggests that D836 relies on particular residues to allow 
for the retention of Ire1 stress signalling (S837, T844 and S850). HAC1 mRNA and KAR2 
mRNA analysis via northern blot using single point mutants that make up the D836A-P-A 
mutants (D836A, S837A, S840A, S841A, T844A and S850A) would allow for the effect 
of phosphorylation at each of these residues to be assessed in terms of RNase activity. This 
would be of great interest as the S850A mutant in Y01907 strain possessing the S850A 
mutation shows increased survivability of ER stress and any increase in HAC1 mRNA 
should become apparent in the northern blot data. To test this further, mutants possessing 
increasing a-loop phosphorylation sites and containing a S850A mutation in some cases 
and not in others could be investigated using the same methodology as presented in this 
thesis. This would allow an investigation into if S850 is providing a level of Ire1 activation 
control dependent on phosphorylation. This is of interest, as with the D836A mutants 
increased survivability, as it may have commercial applications such as in development of 
therapeutics to allow cells to survive under higher protein accumulation stress such as that 
seen in neurodegenerative diseases or in recombinant protein production.  
10.2.2 What is the active conformation of the Ire1 phospho-acceptor mutants? 
The examination of the conformational changes facilitated by both nucleotide binding to 
the NBP resulting from both phosphorylation of the a-loop and by D836 with lack of 
phosphorylation by protein crystallography would be of great interest. This would confirm 
if it is indeed a conformational change that is occurring or another process follows 
nucleotide binding promoting RNase activity of Ire1. Furthermore, this investigation of 
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conformational change could include an increasing number of phosphorylation site 
mutants to determine if there is a preferential order to phosphorylation and if this infers a 
tighter conformation of the RNase domain under ER stress conditions. Alongside this, 
mutations to the anchor points of the activation segment may allow for the role of these 
points and possible interactions with phosphorylation residues to be investigated.  
10.2.3 Nucleotide binding by Ire1 mutants 
The rates with which Ire1 a-loop mutants can bind ADP and ATP under stress conditions 
would also be interesting. This would provide information on how much of an impact the 
a-loop phosphorylation state has on nucleotide binding efficiency. Furthermore, the 
investigation of the rates of hydrolysis of ATP would allow a better understanding between 
the phosphorylation state of the a-loop and its effect on kinase activity. 
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